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ABSTRACT OF DISSERTATION

THE INFLUENCE OF MEMBRANE CHOLESTEROL-RELATED SHEAR STRESS
MECHANOSENSITIVITY ON NEUTROPHIL FLOW BEHAVIOR
Hypercholesterolemia is a dominant risk factor for a variety of cardiovascular diseases
and involves a chronic inflammatory component in which neutrophil activity plays a
critical role. Recently, fluid shear stress mechanotransduction has been established as a
control mechanism that regulates the activity of neutrophils by reducing the formation of
pseudopods and the surface expression of CD18 integrins, thereby rendering these cells
rounded, deformable, and non-adhesive. This is critical for maintaining a healthy
circulation, because chronically activated neutrophils not only release excess cytotoxic
and degradative agents but also exhibit a reduced efficiency to pass through the small
vessels of the microcirculation leading to increased microvascular resistance. We
hypothesized that aberrant neutrophil mechanosensitivity to fluid shear stress due to the
altered blood environment (i.e., excess plasma cholesterol) is a contributing factor for
elevated hemodynamic resistance in the microcirculation associated with
hypercholesterolemia. For this purpose, the present work firstly showed that the
sensitivity of neutrophils to fluid shear stress depends on the cholesterol-dependent
fluidity of the cell membrane, and that, in the face of hypercholesterolemia, the
neutrophil mechanosensitivity highly correlated with the plasma levels of free
cholesterol. The second part of this project demonstrated that, when subjected to shear
stress fields, leukocyte suspensions exhibited transient (within 10 min of flow onset)
time-dependent reductions in their apparent viscosity. Moreover, shear-induced changes
in viscosity of cell suspensions were influenced by disturbances of membrane cholesterol
and fluidity in a fashion similar to that for shear-induced pseudopod retraction. Finally,
the third part of this work provided evidence that neutrophils played a role in
hypercholesterolemia-related impairment of flow recovery response to transient ischemia.
In conclusion, results of the current work provided the first evidence that cholesterol is an
important component of the neutrophil mechanotransducing capacity and impaired
neutrophil shear mechanotransduction may disturb the blood flow rheology, leading to
elevations in the apparent viscosity as well as in the resistance. This cholesterol-linked
perturbation may be a contributing factor for the pathologic microcirculation associated
with hypercholesterolemia.

Keywords: Mechanotransduction; deactivation; pseudopod retraction; neutrophil-platelet
binding; flow rheology.
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CHAPTER 1 INTRODUCTION
Hypercholesterolemia is a dominant risk factor for a variety of cardiovascular
diseases and involves a chronic inflammatory component at both macro- and microcirculatory levels [1, 2]. While it has long been appreciated that monocytic and
lymphocytic immune cells contribute to the initiation/development of arterial diseases in
hypercholesterolemia, only recently has a growing body of evidence emerged that
chronically activated neutrophils also play a critical role in the hypercholesterolemiarelated disorders [2-4].
Neutrophils make up the majority (approximately 60 – 75%) of the nucleated
leukocytes in human blood with the remaining being monocytes and lymphocytes. As the
principal gatekeepers of the acute inflammatory response of the body’s immune system,
neutrophils are extremely sensitive to inflammatory stimuli allowing them to rapidly (i.e.,
on the order of milliseconds) transition from an inactivated to an activated state. Despite
the critical role of neutrophils in acute inflammation, their activity must be tightly
controlled under physiological (i.e., non-inflamed, non-pathological) conditions not only
because of their cytotoxic and biodegradative potential but also due to their rheological
(i.e., flow) behavior particularly in the microcirculation.
Recently, fluid shear stress mechanotransduction has been established as an antiinflammatory mechanism for neutrophils under physiological conditions [5]. Fluid shear
stress deactivates neutrophils by reducing the formation of pseudopods and the surface
expression of CD18 adhesive molecules. As such, this mechanism serves to maintain
cells in a rounded, deformable, and non-adhesive state, ensuring their efficient transit
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through the microvasculature. The importance of this control mechanism is supported by
the connection between impaired shear responses by neutrophils and increased peripheral
vascular resistance in cardiovascular diseases [6, 7]. Along this line, it is possible that
loss of the fluid shear stress regulation of cell activity is a contributing factor for the
elevated neutrophil activation and the disturbed microvascular blood flow rheology
associated with hypercholesterolemia. This is reasonable particularly because the plasma
membranes of neutrophils that are enriched in mechanosensors undergo significant
biological and physicochemical changes in the face of hypercholesterolemia with
potential effects on the cellular shear stress mechanosensitivity (i.e., the degree to which
cells respond to shear stress).
Therefore, we hypothesized that aberrant neutrophil mechanosensitivity to fluid
shear stress due to the altered blood environment (i.e., excess plasma cholesterol) is a
contributing factor for elevated hemodynamic resistance in the microcirculation
associated with hypercholesterolemia.
To address this hypothesis, the present study completed the following specific
aims:
1) Establish a link between extracellular cholesterol levels, the cell membrane,
and the shear stress mechanosensitivity of neutrophils;
2) Correlate neutrophil shear mechanosensitivity with their flow behavior;
3) Verify in vivo the connection between neutrophil shear mechanotransduction
and blood flow regulation during reactive hyperemia in response to transient
blood occlusion.
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CHAPTER 2 BACKGROUND
2.1 Neutrophil Activation and Its Rheological Consequences
Neutrophils undergo activation in response to a wide range of stimuli including
cytokines (e.g., interleukin-8), leukotrienes (e.g., leukotriene B4), platelet-activating
factor (PAF), N-formyl-Met-Leu-Phe (fMLP, an exogenous peptide), and etc. [8].
Specifically, binding of activators to G-protein coupled receptors (GPCRs) on neutrophils
initiates “inside-out signaling” that transitions these cells into an activated phenotype [9].
Neutrophils can also be activated by their contact with activated endothelial cells (ECs)
or platelets, i.e., through the engagement of adhesive molecules (selectins, integrins) with
their counter-receptors (“outside-in signaling”) [9, 10].
Typically, neutrophil activation is manifested by physical changes, notably
extension of pseudopods and binding to other blood borne cells (e.g., leukocytes,
platelets), as well as by biochemical changes including up-regulation of adhesive
integrins (e.g., CD18 integrins consisting mainly of LFA-1 and Mac-1), degranulation
with release of proteolytic enzymes (e.g., myeloperoxidase or MPO), and generation of
reactive oxygen species (ROS; e.g., O2-, H2O2) [8, 9]. These features enable neutrophils
to adhere to and migrate on the endothelium as well as transmigrate into target tissues to
perform their immunological functions (e.g., phagocytosis, tissue repair).
Cell activation-dependent changes in the neutrophil geometry and adhesivity also
have a physical effect on their flow behavior. For example, projection of F-actin enriched
pseudopods leads to increases in cell size, morphological irregularity, and stiffness [8].
Moreover, activated neutrophils likely bind to other leukocytes or platelets to form larger
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aggregates. All these features physically hinder the transit of neutrophils through the
microcirculation and may elevate peripheral hemodynamic resistance, considering that
the microvascular diameters (4 – 100 µm) are comparable to the cell dimensions [4, 8]. In
the skeletal muscles, the contribution of leukocytes (mainly neutrophils) to microvascular
resistance has been estimated to range from about 2% up to 20% at physiological cell
counts. The leukocyte contribution can further increase to 15 – 50% of the whole organ
resistance upon cell activation [11-13].
Two main mechanisms have been proposed to describe the effects of activated
leukocytes on the hemodynamics of microvascular blood flow (e.g., in the skeletal
muscle). In the pre-capillary arterioles (the primary resistance microvasculature),
activated leukocytes, particularly neutrophils, are capable of releasing vasoactive
substances that influence vascular tone via effects on the endothelial regulation of blood
vessel diameter. In this regard, O2- produced by activated neutrophils has been shown to
annihilate endothelial-derived nitric oxide (NO) in vitro [14] and thereby promote
vasoconstriction. Vasoconstriction due to leukocyte activation has been reported to
increase in cardiovascular diseases [15, 16].
Another plausible mechanism is that activated neutrophils, because of their
increased cell size and reduced deformability, have increased difficulty to transit through
the small vessels (e.g., pre-capillary arterioles, capillaries, post-capillary venules) [8].
There are several ways by which these manifestations of neutrophil activation may
influence microvascular flow resistance (Fig. 2.1). In some cases, neutrophils that are
activated may disrupt the motion of red blood cells (RBCs) either by reducing their
velocities in the capillaries [17] or by displacing them from axial positions and causing
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more RBC collisions with a detrimental impact on the apparent viscosity of blood [18].
Both of these possibilities predictably result in elevations in local hemodynamic
resistance. These disturbances of the RBC flow characteristics may be further
exaggerated by the adhesive interactions between neutrophils with other leukocytes or
platelets [19, 20]. Moreover, at locations where leukocyte dimensions are larger than that
of the downstream lumen, activated cells cannot squeeze through such tiny tubes and will
be temporarily trapped, which, if increased in numbers, will significantly raise the local
resistance [8, 11, 13]. Finally, once neutrophils adhere to endothelium, e.g., in the postcapillary venules, they may dramatically increase flow resistance by reducing the
effective lumen cross-sectional diameters particularly because resistance is inversely
proportional to the vessel radius to the fourth power [21-23].

Figure 2.1 Rheological impact of leukocyte activation on the blood flow in the
microcirculation.
Sustained activation, e.g., due to proinflammatory stimuli, hinders leukocyte passage
through the small vessels either by promoting pseudopod projections or through enabling
cell adhesion to the vascular wall. Ultimately, these may elevate peripheral resistance and
contribute to microvascular dysfunctions [4].
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In summary, neutrophils, in addition to their immunological function, play a
critical role in determining the blood flow rheology of the microcirculation.
Sustained/dysregulated neutrophil activation may underlie the disturbed or reduced
microvascular blood flow associated with a variety of cardiovascular diseases such as
hypercholesterolemia-related disorders.

2.2 Neutrophil Involvement in Hypercholesterolemia-Related Microvascular
Dysfunctions
Hypercholesterolemia is typically viewed as a disease of the large arteries (e.g.,
atherosclerosis). It, however, also chronically inflames the microcirculation [2], which is
thought to be linked to impaired microvascular flow regulation. Such microvascular
dysfunction is particularly evident when considering a tissue’s response to ischemic
reactive hyperemia, a transient elevation in blood flow (i.e., a peak flow overshoot) in
response to an acute period of stasis (no-flow condition) [24, 25].
During reactive hyperemia, tissue blood flow is transiently restricted and then
reinstated. Downstream of the occlusive event, blood flow is momentarily stopped until
release of restriction, after which blood flow overshoots to a peak value and then recovers
to the original blood flow level prior to occlusion. Shear stress-sensitive endothelial
events (e.g., NO release) are thought to control the blood vessel myogenic activity during
this response by regulating vascular smooth muscle cells in the arterioles that feed into
the capillaries [25]. However, endothelial function is reportedly not the sole contributor
to changes in ischemic reactive hyperemia. In fact, only ¼ of the factors that govern
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vasoactivity is attributed to the endothelium, even after ischemia [26]. In some cases,
reactive hyperemia is independent of endothelial activity [27].
The dysregulated microvascular state is thought to arise, in part, from chronic
leukocyte activity in the venules [24]. It has also been attributed to neutrophils and
neutrophil-platelet aggregates that lead to dysregulation of the endothelium in the precapillary arterioles [28]. However, neutrophil/platelet binding to endothelium is debatable
due to the high flows in the arterioles that reduce leukocyte residence times at the vessel
wall and the high shears that avert firm binding. Thus, it has been suggested that an
elevated state of inflammation in the blood translates, via soluble mediators, into
arteriolar dysfunction [29].
Neutrophils in the face of hypercholesterolemia exhibit elevated surface
expression of CD18 integrins, particularly Mac-1 (CD11b/CD18), as well as enhanced
degranulation and ROS production [30-32]. As a result, enhanced neutrophil homotypic
(i.e., binding to other neutrophils) and/or heterotypic (binding to other leukocytes or
platelets) aggregation has been observed in hypercholesterolemia contributing to
increased levels of rolling, adherent, and migrating neutrophils in the microvasculature
[2, 33-36]. Notably, these phenotypic changes in microvasculature occur long before the
appearance of fatty streak lesions in the large arteries of animals placed on high fat
(HFD), i.e., a proatherogenic, diet [36, 37]. Therefore, neutrophils may contribute to the
onset and/or progression of atherosclerosis by initiating or exacerbating microvascular
dysfunctions. For instance, chronically activated neutrophils may disturb/reduce the
blood flow in the microcirculation or vasa vasorum of the large vessels (e.g., aorta),
leading to disrupted vascular (i.e., adventitial or medial) wall perfusion and resulting in
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inflammation-related vessel tissue injury followed by atherogenesis (i.e., from within the
vessel wall to the luminal surface) [38-40].
Despite the critical role of neutrophil activation in hypercholesterolemia-induced
microvascular dysfunctions, the original triggers for cell activation are still controversial.
In this regard, a defective mechanotransduction by neutrophils of fluid shear stress, which
has been established as anti-inflammatory for leukocytes, may be a contributing factor for
the elevated cell activity in the face of hypercholesterolemia.

2.3 Mechanobiological Regulation of Neutrophil Activity by Fluid Shear Stress
In general, the scientific literature describing vascular mechanotransduction and
its role in vascular biology point to the following general paradigm, i.e., exposure of
vascular cells to physiological levels of fluid flow-derived shear stress (the tangential
force per unit area exerted on the cell surface) under normal non-inflamed (i.e., nonpathological, non-diseased, non-pathogenic) conditions correlates with quiescence (i.e.,
baseline activity) [5, 41]. For the blood borne neutrophils, fluid shear stress (1 – 10
dyn/cm2) mechanobiologically restricts cell activation by minimizing pseudopod
projection and cell surface expression of CD18 adhesion molecules. Other attributes of
shear-induced neutrophil deactivation include depolymerization of the F-actin
cytoskeleton, cell detachment, reduced phagocytic activity [42, 43] and a pro-apoptotic
phenotype [44]. The role of fluid flow stimulation to control the activity of leukocytes is
supported by the reported connection between impaired leukocyte shear responses and
increased hemodynamic resistance in cardiovascular diseases [6, 7]. Taken together, the
reported evidence points to a fundamental contribution of an impaired neutrophil shear
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mechanotransduction in the dysregulation of microvascular blood flow under
hypercholesterolemia.

2.3.1 Control of pseudopod activity in neutrophils by shear stress
Pseudopod

retraction,

the

most

overt

(i.e.,

noticeable)

morphological

manifestation of the cell-inactivating effects of fluid shear stress, was first observed for
non-cytokine-stimulated human neutrophils migrating on a glass surface and subjected to
a non-uniform flow field imposed by a micropipette with a tip of diameter in the range of
4 – 8 µm [43]. This situation modeled brief and spontaneous periods of blood stasis
followed by an acute onset of flow, a typical scenario in the microvessels particularly
during post-ischemic reactive hyperemia. Within 2 min of the onset of micropipette flow,
migrating neutrophils retracted their existing pseudopod and became rounded. Notably,
using intravital microscopy, the same investigators demonstrated that neutrophils in the
venules of the rat mesentery sediment, extend pseudopods, and migrate on the vascular
endothelium during blood stasis. However, these same cells retracted pseudopods and
detached into the flow field upon reintroduction of fluid flow [42, 43, 45]. The ability of
shear stress to minimize pseudopod activity has also been further confirmed for nonadherent heterogeneous leukocyte populations [46] exposed to a constant shear field (5
dyn/cm2) in a cone-plate viscometer.
Notably, the shear-induced pseudopod retraction response by neutrophils is
depressed upon treatment of cells with threshold concentrations of biochemical agonists,
such as fMLP (>10-8 M) and PAF (>10-7 M) [42]. This commits the neutrophils to an
activated phenotype and leads to their entrapment in microvessels due to increases in
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adhesivity, size, and stiffness [42, 43, 47]. Thus, during inflammation, the biochemical
milieu of the neutrophil overrides mechanobiological deactivation. This relationship
further substantiates an anti-inflammatory role for fluid shear stress in the physiological
non-inflamed condition (i.e., in the absence of threshold levels of cell agonists).
Currently, the formyl peptide receptor (FPR), a cell membrane-bound GPCR
implicated in the regulation of neutrophil chemotaxis, has been shown to be a critical
mechanosensor for neutrophils to sense and respond to fluid shear stress. Overexpression
of FPR in undifferentiated human promyelocytic leukemia (HL60) cells imparts on these
cells the ability to form pseudopods as well as to retract them in response to fluid shear
stress [48]. In contrast, differentiated neutrophilic HL60 (dHL60) cells, after being
transfected with siRNA to block FPR expression, exhibit an attenuated pseudopod
retraction response to shear exposure, despite the fact that these cells retain the ability to
project pseudopods because of the presence of other cytokine-related GPCRs [48].
Since leukocyte pseudopod projection is controlled by the polymerization of Factin, a mechanism involving GPCRs, receptors that control dynamics of the F-actin
cytoskeleton, has been proposed for shear-induced pseudopod retraction response by
neutrophils [5]. In fact, GPCRs, e.g., FPR, under shear flow may undergo a
conformational shift from an active structure to an inactive configuration, leading to
reductions in the activity of Gαi [48]. This reduces the cytosolic activity of the key small
guanine triphosphate-binding phosphatases (e.g., Rac1, Rac2) involved in actin
polymerization [45]. As such, fluid shear stress inhibits or interferes with the ability of
neutrophils to form and sustain pseudopod projections. In support of this, a rapid
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decrease in F-actin content in neutrophils has been observed in parallel with pseudopod
retraction in response to fluid shear stress [49, 50].

2.3.2 Regulation of CD18 expression on the surface of neutrophils by shear stress
CD18 integrins make up a family of heterodimeric cell-cell adhesion molecules
that share a common β2-subunit; LFA-1 (i.e., CD11a/CD18) and Mac-1 (i.e.,
CD11b/CD18) are the primary subtypes that, during inflammation, mediate firm adhesion
of leukocytes to other cells (e.g., ECs, platelets) [9, 51].
Fluid shear stress, in addition to modulating CD18 interactions with their ligands
(e.g. ICAM-1) during inflammation [51, 52], regulates integrin dynamics on the
neutrophil surface under conditions that mimic low activation states. Under non-inflamed
conditions, migrating neutrophils exposed to shear flow redistribute their membraneassociated CD18 receptors from areas of high shear stress to regions where shear is
minimal, i.e. at focal adhesions. Shear exposure also reduces the total amount of CD18
integrins on the surfaces of migrating and non-adherent neutrophils even in the presence
of inflammatory mediators, e.g. fMLP [42, 53]. Considering the role of CD18 integrins,
particularly LFA-1 and Mac-1, in strengthening neutrophil attachment to other cells or
surfaces, shear-mediated reductions in CD18 appear to serve to either prevent cells from
firm adhesion [54] or facilitate membrane detachment critical for an intact pseudopod
retraction response by adherent neutrophils under shear [53]. Therefore, shear-induced
down-regulation of CD18 is another anti-inflammatory mechanism for neutrophils in a
non-inflamed environment to maintain neutrophils in a non-adhesive state.
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The mechanism underlying shear-induced reductions in CD18 surface levels
involves its proteolysis (i.e., cleavage) off the surfaces of migrating and suspended
neutrophils. Reportedly, shear-induced cleavage of CD18 integrins by neutrophils
requires lysosomal cysteine proteases (e.g., cathepsin B) that are released under shear
[53, 54]. It also requires fluid flow-related conformational changes in the extracellular
domains of CD18 integrins to expose the cleavage sites for cysteine proteases [53]. The
exact role of CD18 integrin cleavage in the mechanobiology of the leukocytes as it relates
to microvascular flow regulation, however, is still unclear.

2.3.3

Fluid

shear

stress

mechanotransduction

and implications in

vascular

pathophysiology
It is apparent that, by minimizing formation of pseudopods and surface expression
of CD18 integrins, fluid shear stress mechanotransduction maintains neutrophils in a
rounded, deformable, and non-adhesive state to ensure that these cells smoothly,
optimally, and efficiently pass through the small vessels in the microcirculation with
minimal disturbance.

In doing so, shear stress mechanotransduction may serve to

maintain circulation in a healthy state to avoid the detrimental effects of cell activation
not only on the vascular tissues but also on microvascular blood flow (Fig. 2.1).
Along this line, attenuated neutrophil shear responses have been implicated in the
microvascular pathobiology associated with hypertension [7]. Specifically, the blood
from spontaneously hypertensive rats (SHRs) is characterized by elevated numbers of
circulating neutrophils that project pseudopods but exhibit depressed expression of
adhesion molecules (e.g., selectins, CD18) compared to cells from normotensive animals
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[55-57]. Although the increased activity of SHR-derived neutrophils is not associated
with increased adhesion to microvascular endothelium [5], their increased numbers raise
peripheral vascular resistance [7]. One possible explanation is that circulating activated
neutrophils in SHRs release vasoactive substances to promote vasoconstriction as
documented for atherosclerosis [15, 58, 59]. Extensive evidence, however, points to a
rheological effect of leukocyte activation on microvascular resistance above the effect
that would occur due to the elevated leukocyte numbers, alone [8, 60, 61]. Specifically,
pseudopod formation by the SHR-derived leukocytes likely further enhances resistance
by increasing the tumbling of leukocytes and thus causing more disturbances in the flow
profile of the surrounding RBCs. This effect on the apparent viscosity of blood would
have an enhancing effect on hemodynamic resistance and upstream blood pressure (Fig.
2.1).
Notably, fluid flow mechanotransduction (i.e., pseudopod retraction in response
to shear exposure) is lacking for neutrophils from SHRs. In some cases, cells extend
cellular projections under flow stimulation, defined as a “reversed” pseudopod retraction
response to fluid shear [7]. One possible mechanism underlying the abnormal shear
mechanotransduction in SHRs relates to plasma glucocorticoids and their receptors on the
neutrophil surface [62, 63]. Glucocorticoid-treated [6] rats, like SHRs, exhibit elevated
peripheral resistance in the microcirculation with elevated numbers of neutrophils that
lack a pseudopod retraction response to shear stress. Interestingly, it is possible that
glucocorticoids may impact neutrophil responses to shear stress stimulation via their
effects on receptor-mediated biological signaling. It, however, should be noted that
glucocorticoids have pleiotropic effects including their ability to fluidize the cell
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membrane.

For example, Gerritsen et al showed that glucocorticoids influence

eicosanoid generation in microvessel ECs via their effects on membrane composition and
fluidity [64].

Moreover, glucocorticoids have been shown to reduce the membrane

fluidity of leukemia cells [65].
As such, a defective shear mechanotransduction, e.g., due to a pathological blood
environment, may not only lead to sustained neutrophil activation but also result in
disturbed blood flow with reduced downstream tissue perfusion. Moreover, it is possible
that the ability of fluid shear stress to alter neutrophil activation is related to not only the
biological but also the physicochemical status of the leukocyte membrane.

2.4 Role of Cell Membrane in Regulating Neutrophil Shear Mechanosensitivity
The present study adopted an approach to define the shear mechanosensitivity of
the neutrophil as a potential quantitative measure of the ability of fluid shear stress to
deactivate neutrophils. The possibility that perturbations in leukocyte shear
mechanosensitivity affect the regulation of leukocyte activity with impact on cell
rheological behavior in the microvessels has implications in the reported chronic
inflammatory phenotype of the microcirculation under disease conditions, such as
hypercholesterolemia [2]. One way by which the extracellular factors influence
neutrophil shear mechanosensitivity is through the cell membrane.
The cell membrane is strategically positioned at the interface between the intraand extra- cellular milieu. Moreover, the cell membrane is enriched in putative fluid flow
mechanosensors (e.g., various GPCRs [48, 66, 67], CD18 integrins [53, 54], ion channels
[68], etc.) which undergo conformational changes under the actions of fluid shear stress.
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As a supporting medium for these transmembrane proteins, cell membrane may play a
critical role in regulating their sensitivity to fluid shear stimulation by influencing the
ability of these molecules to undergo structural shifts that determine their functions.
In the case of hypercholesterolemia, the plasma membranes of vascular blood
cells including the leukocytes and RBCs [69, 70] reportedly undergo changes in their
lipid composition, i.e., increased membrane cholesterol. As a consequence, the biological
and physical properties of cell membranes are also changed. For example, excess
cholesterol in the membranes can disrupt the organization of lipid rafts [71], the
cholesterol-rich microdomains that act as signaling platforms to orchestrate outside-in
and inside-out signal transduction [4]. By dissociating the mechanosensory protein
receptors from the lipid rafts, membrane cholesterol enrichment can interfere with their
signaling cascades with effects on their response to fluid shear stress. In fact, lipid rafts
(e.g., caveolae, a subtype of lipid rafts) have been implicated as mechanotransduction
centers for the mechanotransduction of shear stress and pressure in ECs [72-74].
Alternatively, cholesterol enrichment can also influence the physical properties of
membranes, among which the fluidity of lipid bilayer has received increasing attention.
Specifically, increases in cholesterol reduce membrane fluidity [75, 76], thereby affecting
the dynamics of membrane-associated protein sensors. This is because membrane fluidity
can influence the mobility (e.g., lateral diffusion) [77] and structural flexibility [78] of
membrane proteins. Membrane fluidity, in fact, has been reported to impact the
conformation-dependent activation of GPCRs in ECs by affecting their structural changes
[66]. Therefore, this physical property may influence neutrophil shear mechanosensitivity
via its effects on shear-induced conformational activity.
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In addition to the potential effects on membrane protein sensors, cell membranes
may affect the mechanosensitive release or production of bioactive molecules that
participate in or regulate the mechanotransduction processes in cells. For example,
cholesterol-related membrane properties (e.g., permeability, fluidity) may affect the
transmembrane release of cathepsin B, a key enzyme required for shear-induced CD18
cleavage [53, 54]. Moreover, it has been reported that O2- blocks shear-induced
pseudopod retraction response [46]. It is, therefore, possible that membrane fluidity
influences neutrophil shear mechanotransduction by affecting the activity of membraneassociated NADPH oxidase [79], an main source of O2-.
As such, the neutrophil mechanotransduction is tied to the state of the cell
membrane. Along these lines, in the face of hypercholesterolemia, excess cholesterol in
the cell membranes of neutrophils may contribute to abnormalities in their sensitivity to
fluid shear stress to the point of impaired shear-induced cell deactivation and
compromised microvascular flow. In this regard, the present study focused on the role of
blood cholesterol milieu in the regulation of leukocyte mechanosensitivity of fluid shear
stress. In doing so, the present study not only examined how cholesterol levels impact
the mechanosensitive regulation of leukocyte activity, but also explored a potential
mechanism related to the dysregulation of microcirculation in hypercholesterolemia.
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CHAPTER 3 CHARACTERIZATION OF CELL-DEACTIVATING EFFECTS OF
FLUID SHEAR STRESS
Pseudopod extensions and firm adhesion to other cells (e.g., ECs, platelets) are
two major ways by which cellular activation impedes neutrophil transit through the
microvessels of microcirculation (Fig. 2.1). In this regard, shear-induced pseudopod
retraction and CD18 cleavage by neutrophils may serve to optimize their flow rheology
in the microcirculation. To provide a basis for the assessment of this possibility, studies
in the present section were designed to establish the basic characteristics (e.g., shear
exposure time- and stress magnitude- dependence, dependence on cell and integrin
subtypes) of the pseudopod retraction and/or CD18 cleavage responses to fluid shear
stress. In order to demonstrate the anti-inflammatory role of CD18 cleavage by
suspended cells, we further tested whether an impaired CD18 cleavage response
influences fibrinogen-mediated neutrophil-platelet binding, which has been reported to
exert dramatic effects on hemodynamic resistance of microvascular blood flow [19, 20].

3.1 Methods
3.1.1 Cells
3.1.1a Neutrophilic-like dHL60 cells
HL60 cells were purchased from the American Type Culture Collection (ATCC)
and cultured in RPMI 1640 (Invitrogen) supplemented with 10% heat-inactivated fetal
bovine serum (FBS; Hyclone) and 1% L-glutamine/penicillin/streptomycin solution (LGPS; Sigma Aldrich) under standard incubator conditions (i.e., a humidified, 5%
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CO2/95% air environment maintained at 37 °C). Neutrophilic differentiation was induced
by incubating HL60 suspensions (at 3x105 cells/ml) with 1.25% DMSO (ATCC) for 6
days. Cells were then washed twice with isotonic phosphate-buffered saline (PBS;
Mediatech) and cultured in fresh FBS/L-GPS-supplemented RPMI media for an
overnight period of time prior to use. Neutrophilic differentiation was confirmed by the
identification of multi-segmented nuclei stained with 4',6-diamidino-2-phenylindole
(DAPI; MP Biochemicals).

3.1.1b Human peripheral blood neutrophils
All procedures used to collect and handle human blood samples in the present
study were approved by the Institutional Review Board at the University of Kentucky
(Lexington, KY).
Fresh human peripheral blood was drawn from asymptomatic volunteers into K2EDTA-coated vacutainers (Becton-Dickinson) using standard venipuncture. For
experiments to examine shear-induced CD18 cleavage and its effects on leukocyteplatelet binding, blood was chilled at 4 °C for 30 min. The leukocyte-enriched plasma
(containing neutrophils, monocytes, lymphocytes, platelets and sporadic RBCs) was then
harvested after 1xg sedimentation at room temperature (RT) for 45 min.
To explore neutrophil-specific behavior, we also conducted experiments with
purified neutrophils. In this case, human neutrophils were isolated by single-step gradient
centrifugation

in

PolymorphprepTM

solution

18

(Axis-Shield)

according

to

the

manufacturer’s instructions. At the end of isolation procedures, cells were resuspended in
PBS at 2x107 cells/ml. Using this method, cell suspensions were >90% neutrophils.

3.1.2 Shear stress exposure
A custom cone-plate rheometer was used in the present study. This rheometer
consisted of a stainless steel cone-plate setup (cone angle of 1°) that was fitted to a
computer-controlled CNC mill (Sherline) as established previously [53, 54]. At RT, up to
3 ml of cell suspensions was placed on the plate and the cone in contact with cell
suspensions was spun at a desired speed to expose cells to a constant shear stress field
defined by Couette approximation. The shear stress created in this rheometer was
calculated using the following equation:
𝜏 = 𝜇 × 2𝜋𝜔/(60 sin 𝜃),

where τ is the shear stress (dyn/cm2), µ is the viscosity (P), ω is the cone rotational rate
(rpm), and θ is the cone angle in degrees [80]. For a cell suspension with an averaged
viscosity of ~ 0.01 P, to achieve a shear stress of 2.5, 5, 7.5, or 10 dyn/cm2, the cone
rotational rate was set at 41, 82, 123, or 164 rpm, respectively. The shear time ranged
from 1 to 10 min. Unsheared controls were cells maintained on the plate without spinning
cone for a matched time period.
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3.1.3 Analysis of shear-induced pseudopod retraction by dHL60 cells
3.1.3a Experimental details
Neutrophilic dHL60 cells were diluted 1:20 (v/v) with Hanks’ buffered saline
solution (HBSS; Invitrogen). To facilitate the analyses of cell-deactivating effects of
shear stress, 10 nM fMLP (Sigma Aldrich) was used to mildly stimulate cells for 5 min;
previous studies showed that fMLP at 10 nM results in elevated leukocyte activity
without compromising the shear response [42]. Subsequently, cells were exposed to 5
dyn/cm2 for 0 – 10 min, or to 0 – 10 dyn/cm2 for 5 min. After experiments, cells were
immediately fixed in 1% p-formaldehyde (Electron Microscopy Sciences) for >10 min.

3.1.3b Microscopic analysis of pseudopod activity
Fixed cells were permeabilized in 0.1% triton X-100 in PBS for 1 min, labeled
with 2 µg/ml DAPI, and immediately observed with an IX-70 inverted fluorescence
microscope (Olympus) at a 1000X magnification and ultraviolet illumination
(excitation/emission wavelength: 358/461 nm). For each sample, at least 20 cells were
visually assessed; the number of cells that expressed at least 1 cellular projection (Fig.
3.1) was counted and the percentage of cells with pseudopod(s) was used to quantify the
cell pseudopod activity level.
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Figure 3.1 Representative images of quiescent and activated cells with pseudopod(s).

3.1.4 Analysis of shear-induced CD18 cleavage by suspended leukocytes
3.1.4a Experimental details
Within 3 h of blood collection, human leukocyte-enriched plasma was diluted
1:10 (v/v) in HBSS supplemented with 2.5 mM CaCl2 (Sigma Aldrich) and subsequently
exposed to 2.5, 5, or 10 dyn/cm2 cone-plate shear stress at RT for up to 10 min. Controls
were leukocyte populations maintained under no-flow, but otherwise similar
experimental conditions.
To confirm the CD18 proteolysis, some experiments were conducted with cells
pretreated with E64 (MP Biochemicals), a cysteine protease inhibitor known to block
shear-induced reductions in CD18 surface expression [54]. For these studies, cells were
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incubated in Ca2+-supplemented HBSS containing 28 µM E64 for 10 min prior to shear
exposure.
At the end of experiments, cells were fixed with 0.8% fresh p-formaldehyde for
immunofluorescence analysis of CD18 expression or leukocyte-platelet binding (see
section 3.1.4b).
To examine the effects of CD18 cleavage on fibrinogen binding, naïve or E64treated purified neutrophils (1x106 cells/ml) in Ca2+-supplemented HBSS were exposed to
shear flow (10 dyn/cm2; 10 min) followed by fibrinogen binding assay (section 3.1.4b).

3.1.4b Fluorescence-based flow cytometry
An LSR II flow cytometer (Becton-Dickinson) with Becton-Dickinson FacsDIVA
software was used to analyze cell samples. For each sample, at least 10,000 leukocytes
were acquired. Using WINMDI software (The Scripps Research Institute), populations of
neutrophils, monocytes, and lymphocytes were gated based on their forward (FSC) and
side scatters (SSC) (Fig. 3.2). On average, leukocyte populations tested in the present
study contained approximately 61% neutrophils, 8% monocytes, and 31% lymphocytes
typical of blood [81] under non-inflammatory/non-pathological conditions. We used this
approach to examine CD18 cleavage, leukocyte-platelet binding, and neutrophilfibrinogen binding, as follows.
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Figure 3.2 Representative analysis of antigen expression by flow cytometry.
A: Neutrophils, monocytes, and lymphocytes were gated based on FSC and SSC. B:
Histograms of fluorescence intensity, i.e., CD18-FITC, were plotted for gated cell
populations. The background fluorescence of unstained cells was also overlaid (NoStaining).

I.

Quantification of CD18 cleavage
Fixed leukocytes were washed three times with PBS and blocked with 1% bovine

serum albumin (BSA; Sigma Aldrich) at RT for 30 min.
To quantify CD18 surface expression, cells were stained with antibodies against
CD11a (5 µg/ml; Alexa Fluor®647 conjugated clone 38; Serotec), CD11b (1:10 v/v;
Alexa Fluor®488 conjugated clone ICRF44; Becton-Dickinson), or CD18 (1:10 v/v;
FITC conjugated clone 6.7; Becton-Dickinson) in 1% BSA at 4 °C in the dark for 25 min
[53, 54].

For the quantification of total amount of CD18 integrins (cleaved and

uncleaved), a goat polyclonal antibody against the C-terminus of human CD18 (1 µg/ml;
clone C-20; Santa Cruz) and Alexa Fluor488 conjugated donkey anti-goat IgG (10
µg/ml; Invitrogen) secondary antibody were used to stain the cells using the same
procedure but with 0.1% saponin (Sigma Aldrich) added to the blocking and wash buffers
to permeabilize the cell membranes. After staining, cells were washed three times to
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remove excess, unbound antibodies. The mean fluorescence intensity (MFI) of
fluorescent label bound to each gated population was measured by flow cytometry to
quantify the expression of CD18 integrins (Fig. 3.2).

II.

Quantification of leukocyte-platelet binding
To quantify leukocyte-platelet adhesion, fixed cells were labeled with antibodies

against platelet-specific CD41 (1:20 v/v; FITC conjugated clone VIPL3; Invitrogen)
and/or leukocyte-specific CD45 (1:20 v/v; PE-CyTM7 conjugated clone HI30; BectonDickinson) in PBS at 4 °C in dark for 30 min. Non-specific binding was assessed using
isotype-matched mouse IgG1 (1:20 v/v; Alexa Fluor®488 conjugates; Invitrogen). Using
the LSR II flow cytometer and WINMDI software, the percentage of leukocytes that
exhibited CD41-FITC labeling above a background level (i.e., unstained cells) was
quantified and used as a measure of leukocyte-platelet binding [82, 83] (Fig. 3.3). Some
experiments were conducted using two-color staining (i.e., CD41-FITC and CD45-PECyTM7) to verify that flow cytometry detected leukocyte-platelet interactions and not
platelet-platelet aggregation.
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Figure 3.3 Representative analysis of leukocyte-platelet binding by flow cytometry.
A: Leukocyte-platelet binding was analyzed using a monoclonal antibody against
platelet-specific CD41. Non-specific binding was assessed with an isotype control. B:
The distribution of CD41-FITC intensity was plotted against SSC for leukocytes under
different experimental conditions. Particles exhibiting fluorescence above threshold
levels were considered as leukocyte-platelet aggregates.

III.

Quantification of neutrophil-fibrinogen binding
After shear experiments, live cells were chilled on ice for 2 min and subsequently

incubated with 5 µg/ml Alexa Fluor®488 conjugated fibrinogen (Invitrogen) at 4 ℃ for
10 min with mild agitation followed by fixation with 0.8% p-formaldehyde on ice. Nonspecific binding was assessed by performing the incubations of cells with Alexa
Fluor®488 conjugated fibrinogen in the presence of a 10-fold excess of non-fluorescent
fibrinogen (MP Biomedicals) [84]. The MFI of fibrinogen present on neutrophil
populations was measured by flow cytometry as an indicator of neutrophil-fibrinogen
binding.
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3.2 Results
3.2.1 Pseudopod activity of non-adherent neutrophils is regulated by fluid shear stress
3.2.1a Shear-induced pseudopod retraction by neutrophils is an acute response

Figure 3.4 Shear-induced reductions in pseudopod activity depend on shear
exposure time.
Percentage of dHL60 cells with pseudopods was visually counted after being sheared at
2
5.0 dyn/cm for 0, 2, 5, and 10 min. Data are mean ± SEM from N = 3 experiments. *p <
0.05 compared to t = 0 using one way ANOVA with Bonferroni’s method.

Under static no-flow (i.e., t = 0) conditions, the percentage of cells with
pseudopods was approximately 25%. Despite this low level of pseudopod activity, a
significant (p < 0.05) reduction in the numbers of cells expressing pseudopods in dHL60
cell populations was detected after only 2 min of exposure to 5.0 dyn/cm2 cone-plate
shear stress (Fig. 3.4). Shear exposure for 5 or 10 min also significantly (p < 0.05)
reduced pseudopod formation by dHL60 cells, however, there was no difference in the
percentage of cells exhibiting pseudopods among cell populations exposed to shear stress
for 2, 5, or 10 min (Fig. 3.4).
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3.2.1b Shear-induced pseudopod retraction by neutrophils occurs independently of shear
magnitude within the range of 5 to 10 dyn/cm2

Figure 3.5 Shear-induced reductions in pseudopod activity occur independently of
2
shear magnitudes within 5 – 10 dyn/cm .
2
Suspensions of dHL60 cells were subjected to 0 (control), 5, 7.5, and 10 dyn/cm for 5
min following treatment with 10 nM fMLP for 5 min. Data are mean ± SEM from N = 3
experiments. *p < 0.05 compared to control using one way ANOVA with Bonferroni’s
method.

To facilitate detection of the magnitude dependent effects of fluid shear stress on
pseudopod activity, 10 nM fMLP was used to elevate the pseudopod activity of cell
populations above baseline levels. Stimulating cell populations with 10 nM fMLP for 5
min elevated the percentage of cells with pseudopods to approximately 86%. Preactivation of cells in 10 nM fMLP buffer followed by exposure to 5.0 dyn/cm2 in the
same buffer for 5 min resulted in significantly (p < 0.05) reduced pseudopod activity
(Fig. 3.5). Similar degrees of reductions in pseudopod activity of dHL60 cell populations
were observed after 5-min exposure to 7.5 or 10 dyn/cm2 (Fig. 3.5).
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3.2.2 Shear-induced proteolysis regulates CD18 expression on the surfaces of leukocytes
3.2.2a Shear-induced down-regulation of CD18 surface expression is time-dependent
Under static conditions, the constitutive (i.e., baseline) surface expression of
CD18 integrins by the three main leukocyte subpopulations remained constant
(neutrophils: 216±54 MFI; monocytes: 386±110 MFI; lymphocytes: 80±24 MFI) within
3 h of blood collection (i.e., the time frame for all of our experiments) and was not
affected by the stainless steel plates of our cone-plate rheometer.

Figure 3.6 Fluid flow-mediated reductions in CD18 surface expression require
threshold duration of shear exposure.
A – C: The surface levels of CD18 on neutrophils (A), monocytes (B), and lymphocytes
2
(C) were measured after exposing diluted leukocyte-enriched plasma to 10 dyn/cm shear
stress for 1, 5, and 10 min, and normalized to levels of time-matched cell type-specific
controls (Unsheared; dashed line). Data are mean ± SEM from N = 4 experiments. *p <
0.05 compared to controls using Mann-Whitney Rank Sum test.

Compared with cell populations maintained under static conditions (i.e.,
unsheared controls), heterogeneous leukocyte populations subjected to fluid shear stress
(10 dyn/cm2) for up to 10 min exhibited time-dependent reductions in CD18 surface
levels (Fig. 3.6). Although there were no significant changes in CD18 expression on the
surface of neutrophils, monocytes, or lymphocytes after being sheared for 1 min relative
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to their respective time-matched controls, the CD18 surface levels for each leukocyte
subtype were significantly (p < 0.05) reduced to similar levels (i.e., minimal levels) after
5 and 10 min of shear exposure.

3.2.2b Magnitude-dependence of shear-induced CD18 reductions is leukocyte subtype
specific

Figure 3.7 Fluid flow-mediated reductions in CD18 surface expression require
exposure to a threshold magnitude of shear stress.
A – C: The surface levels of CD18 on neutrophils (A), monocytes (B), and lymphocytes
(C) in the diluted leukocyte-enriched plasma were measured after 10-min exposure to 2.5,
2
5, and 10 dyn/cm shear stress, and normalized to levels of time-matched cell typespecific controls (Unsheared; dashed line). Data are mean ± SEM from N = 4
experiments. *p < 0.05 compared to controls using Mann-Whitney Rank Sum test.

Fluid flow-mediated down-regulation of CD18 surface expression by leukocytes
depended on the magnitude of the applied shear stress. Whereas exposure of neutrophils
and monocytes to 2.5 dyn/cm2 shear stress for 10 min did not lead to significant
reductions in the surface levels of CD18, subjecting these cells to 5 or 10 dyn/cm2
significantly (p < 0.05) reduced the total amount of surface CD18 after 10 min, relative to
unsheared cell type-matched controls (Fig. 3.7). For lymphocytes exposed to the same
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shear field, significant (p < 0.05) reductions in CD18 surface expression were detected
under shear stresses as low as 2.5 dyn/cm2 (Fig. 3.7).

3.2.2c Shear stress reduces CD18 expression on the leukocyte membranes via cleavage of
the integrin ectodomain

Figure 3.8 Shear stress-induced reductions in CD18 surface expression involve
cleavage of the extracellular domain.
A and B: The expression levels of extra- (A) and intra- (B) cellular CD18 by neutrophils
(Ne), monocytes (Mo), and lymphocytes (Ly) in the diluted leukocyte-enriched plasma
2
were measured after 10-min exposure to 10 dyn/cm shear stress, and normalized to
levels of matched cell type-specific controls (Unsheared; dashed line). Data are mean ±
SEM from N = 8 experiments. *p < 0.05 compared to controls using Mann-Whitney
Rank Sum test.

For neutrophils and lymphocytes, exposure to 10 dyn/cm2 shear stress for 10 min
significantly (p < 0.05) reduced binding of antibodies targeting the extracellular domains
of CD18 integrins, but had no detectable effects on the binding of antibodies recognizing
cytosolic CD18 epitopes (Fig. 3.8). These results provide evidence that CD18 integrins
were cleaved off neutrophils and lymphocytes in the extracellular domain due to shear
exposure. A similar pattern of antibody binding was observed for monocytes although
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differences in the amount of antibodies bound to the extracellular domain of CD18
between sheared and unsheared monocytes failed to reach significance (Fig. 3.8).

3.2.2d Shear-induced CD18 cleavage depends on the integrin subtype
Under static conditions, resting leukocytes constitutively expressed CD18 in an
integrin subtype-dependent manner. The three leukocyte subtypes all expressed CD11a
but at significantly (p < 0.05) different levels; monocytes exhibited the highest level of
expression followed by lymphocytes and neutrophils (Fig. 3.9). In contrast, neutrophils
and monocytes displayed similar surface levels of CD11b, while lymphocytes exhibited
undetectable surface expression of this integrin subunit (Fig. 3.9).
In response to shear exposure (10 dyn/cm2; 10 min), CD18 cleavage also occurred
in an integrin subtype-specific fashion. For neutrophils, shear exposure significantly (p <
0.05) reduced the surface levels of CD11b and CD18, but not CD11a (Fig. 3.9). Although
sheared monocytes on average exhibited lower levels of both CD11b and CD18 as
compared to unsheared cells, these differences were not statistically significant (Fig. 3.9).
In the case of lymphocytes, exposure to shear stress significantly (p < 0.05) reduced
surface levels of CD11a and CD18 (Fig. 3.9). These results provide evidence that shear
stress induced cleavage of Mac-1 on neutrophils and monocytes (less robust) but elicited
proteolysis of LFA-1 on lymphocytes.
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Figure 3.9 Shear-induced CD18 cleavage depends on the CD18 subtype.
A – C: The expression levels of CD11a (A), CD11b (B), and CD18 (C) on the surfaces of
neutrophils (Ne), monocytes (Mo), and lymphocytes (Ly), under static condition, were
measured as the mean fluorescence intensity (MFI) of related antibody. #p < 0.05
compared among the three leukocyte subsets using one way ANOVA with Bonferroni’s
correction. D – F: The surface levels of CD11a (D), CD11b (E), and CD18 (F) on
different leukocyte subsets were measured after 10-min exposure to 10 dyn/cm2 shear
stress, and normalized to levels of matched cell type-specific controls (Unsheared; dashed
line). Data are mean ± SEM from N = 3 experiments. *p < 0.05 compared to controls
using Mann-Whitney Rank Sum test.

3.1.2e Protease inhibitor E64 differentially influences CD18 cleavage by leukocytes
under shear
Treatment of leukocyte populations with 28 µM E64 had no effect on their
baseline expression of CD18 integrins under static condition (data not shown). However,
this protease inhibitor significantly (p < 0.05) enhanced surface expression of CD18
integrins by neutrophils subjected to shear stress (10 dyn/cm2; 5 min) in a cone-plate
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viscometer consistent with the blockade of shear-induced cleavage, as compared to
untreated cells exposed to a similar shear field (Fig. 3.10). In contrast, E64 had no
significant effect on the CD18 surface levels of sheared monocytes and lymphocytes
(Fig. 3.10).

Figure 3.10 Protease inhibitor E64 differentially influences CD18 cleavage by
leukocytes under shear flow.
The CD18 surface levels were quantified for E64-treated neutrophils (Ne), monocytes
2
(Mo), and lymphocytes (Ly) after shear exposure (10 dyn/cm ; 5 min) and normalized to
those for cell type-matched controls (untreated cells or UT; dashed line) in the same shear
field. Data are mean ± SEM from N = 5 experiments. *p < 0.05 compared to UT using
Student’s t-test.

3.1.2f Protease inhibitor E64 differentially influences leukocyte-platelet binding under
shear
In the absence of exogenous chemical stimuli, heterogeneous leukocyte
populations under shear flow (10 dyn/cm2; 5 min) exhibited spontaneous platelet binding
(Fig. 3.11A). In comparison, the percentage of cells with bound platelets for all the three
subtypes of leukocytes increased significantly (p < 0.05) after shear exposure. Moreover,
lymphocytes exhibited the lowest level of platelet binding under shear among the three
subtypes.
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Interestingly, whereas E64 did not affect the adhesive interactions between
leukocytes and platelets under static condition (data not shown), treatment with this antiprotease promoted neutrophil-platelet binding under shear exposure. Notably, the
percentage of E64-treated neutrophils binding at least one platelet were significantly (p <
0.05) higher than that observed for untreated cells when exposed to the same shear field
(Fig. 3.11B). In the case of monocytes and lymphocytes, E64 had no detectable effects on
their adhesion to platelets under shear flow (Fig. 3.11B)

Figure 3.11 Protease inhibitor E64 differentially influences leukocyte-platelet
binding under shear flow.
A: The percentage of naïve cells binding at least one platelet was examined for
neutrophils (Ne), monocytes (Mo), and lymphocytes (Ly) under static and shear (10
2
dyn/cm ; 5 min) conditions. #p < 0.05 compared to the same cell type under static
condition using Student’s t-test. +p < 0.05 compared among Ne, Mo, and Ly using one
way ANOVA with Bonferroni’s correction. B: Platelet binding to E64-treated cells was
quantified after shear exposure and normalized to those of cell type-matched nonchemically treated controls (UT; dashed line) in the same shear field. Data are mean ±
SEM from N = 5 experiments. *p < 0.05 compared to UT using Student’s t-test.

3.1.2g Shear-induced CD18 cleavage reduces binding of neutrophils to fibrinogen
Fluid shear stress suppressed binding of neutrophils to fibrinogen, a Mac-1 ligand
that mediates leukocyte-platelet interactions. The amount of fibrinogen bound to
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neutrophils that had been sheared at 10 dyn/cm2 for 10 min was significantly (p < 0.05)
lower than that present on cells maintained under static no-shear conditions (Fig. 3.12).
For cells pretreated with E64, there was no significant difference between sheared and
unsheared samples (Fig. 3.12).

Figure 3.12 Shear stress-mediated CD18 cleavage influences neutrophil-fibrinogen
binding.
The amount of fibrinogen bound to sheared neutrophils was measured and normalized to
that of unsheared cells (dashed line). Data are mean ± SEM from N = 5 experiments. *p <
0.05 compared to unsheared controls using Mann-Whitney Rank Sum test.
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CHAPTER 4 DEPENDENCE OF NEUTROPHIL SHEAR
MECHANOSENSITIVITY ON MEMBRANE CHOLESTEROL
Cholesterol is an essential structural component of cell membranes that plays a
critical role in regulating cell signaling and activity levels. Changes in the content and/or
organization of cholesterol within the plasma membranes have been demonstrated to
influence a number of cell functions for neutrophils or neutrophilic cells including cell
polarization, shape change, actin polymerization, adhesion and migration [85-88]. The
effects of membrane cholesterol modifications take place via impacts on lipid rafts and/or
membrane fluidity.
Studies in this section were designed to explore the role of membrane cholesterol
in the shear stress mechanoregulation of neutrophil pseudopod activity. For this purpose,
cholesterol molecules conjugated with methylated β-cyclodextrin (MβCD) were used as
membrane cholesterol-enhancing agents, particularly because MβCD in this conjugate
has been shown to efficiently deliver cholesterol into the cells within a short period of
incubation [89]. In order to confirm the involvement of membrane fluidity, benzyl
alcohol (BnOH), which fluidizes plasma membranes by increasing membrane free
volume [66], was also used.
Moreover, as an in vivo strategy of membrane cholesterol enrichment in
leukocytes, a low-density lipoprotein receptor deficient (LDLr-/-) murine model of
hypercholesterolemia was used. This model is associated with diet-induced elevations in
blood cholesterol levels that reportedly enhance the membrane cholesterol content of
blood borne leukocytes [90].
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4.1 Methods
4.1.1 Analysis of membrane cholesterol-dependent, shear-induced pseudopod retraction
4.1.1a Shear stress experiments with human whole blood
Whole blood was harvested from human subjects as described in section 3.1.1b.
To increase the membrane cholesterol content of human leukocytes, aliquots of whole
blood was treated with 0 – 10 µg/ml cholesterol:MβCD complexes (Sigma Aldrich) for
15 min, and subsequently incubated in HBSS (1:20 v/v) containing 10 nM fMLP and 0 –
7 mM BnOH (Acros Organics) for 10 min.
After membrane-modifying chemical treatments and cell pre-activation, blood
cell suspensions were subjected to 5 dyn/cm2 at RT for 10 min (see section 3.1.2).
Controls were parallel cell suspensions maintained under no-flow, but otherwise similar
experimental conditions. At the end of experiments, cells were fixed with 1% pformaldehyde and subjected to analyses of pseudopod activity as described in section
3.1.3b. The shear response (%) was calculated using the following equation:
𝑆ℎ𝑒𝑎𝑟 𝑅𝑒𝑠𝑝𝑜𝑛𝑠𝑒 (%)
=

% 𝑐𝑒𝑙𝑙𝑠 𝑤𝑖𝑡ℎ 𝑝𝑠𝑒𝑢𝑑𝑜𝑝𝑜𝑑𝑠𝑠𝑡𝑎𝑡𝑖𝑐 − % 𝑐𝑒𝑙𝑙𝑠 𝑤𝑖𝑡ℎ 𝑝𝑠𝑒𝑢𝑑𝑜𝑝𝑜𝑑𝑠𝑠ℎ𝑒𝑎𝑟
%
% 𝑐𝑒𝑙𝑙𝑠 𝑤𝑖𝑡ℎ 𝑝𝑠𝑒𝑢𝑑𝑜𝑝𝑜𝑑𝑠𝑠𝑡𝑎𝑡𝑖𝑐

4.1.1b Cell viability
In separate experiments, the viability of cell populations was assessed
immediately after the membrane-modifying chemical treatments. A Live/Dead Double
Staining Kit (Calbiochem) that quantifies the uptake of calcein AM (live cell indicator)
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and propidium iodide (dead cell indicator) was used following the manufacturer’s
instructions. Neutrophil viability remained unchanged at >90% after all membranemodifying treatments tested in the present study.

4.1.1c Membrane cholesterol quantification
The free cholesterol in leukocyte membranes was quantified after membranemodifying chemical treatments. Membrane cholesterol was extracted from leukocytes
according to the method of Bligh and Dyer [91]. Briefly, cells (1x106 cells/ml) in 600 µl
ice-cold HBSS were vortexed and incubated with 2.25 ml of a 1:2 v/v
chloroform/methanol solution for 10 min followed by sequential addition of 750 µl of
chloroform and 750 µl of diH2O. After centrifugation at 1900xg for 10 min, the top
alcoholic layer was aspirated and the organic layer was evaporated to dryness at 50 °C.
The extracted cholesterol was reconstituted in 200 µl of 10% TritonX-100 in isopropyl
alcohol. The reconstituted cholesterol was diluted (1:60 v/v) with the color reagent of the
Free Cholesterol E kit (Wako) and incubated at 37 °C for 5 min; the absorbance was
measured at 600 nm with a spectrophotometer (BioTek; μQuant). The concentration of
free cholesterol was calculated from the absorbance readings according to a standard
curve generated following the manufacturer’s instruction.

4.1.1d Quantification of membrane fluidity
The effects of cholesterol:MβCD complexes on membrane fluidity were assessed
using 1-pyrenedecanoic acid (PDA; Molecular Probes) as described previously [92].
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Briefly, leukocyte-enriched plasma was incubated with 5 μM PDA in PBS containing 5
mM EDTA at 37 °C for 1 h, and then subjected to the experimental membrane-modifying
treatments tested in the present study (see section 4.1.1a). Fluorescence emissions were
immediately evaluated for

each

live

cell preparation

using

a

fluorescence

spectrophotometer (Hitachi; F-2500) at wavelengths of 375 nm to quantify monomer (Im)
emission and 470 nm to measure excimer (Ie) emission under 344 nm excitation [92].
Membrane fluidity was expressed as a ratio of Ie/Im. For this analysis, as Ie/Im ratios
increases, membrane fluidity increases.

4.1.2 Analysis of shear stress mechanosensitivity in hypercholesterolemia
All procedures used to collect and handle murine blood samples in the present
study were approved by the Institutional Animal Care and Use Committee at the
University of Kentucky (Lexington, KY).

4.1.2a Mice
Wild-type (WT) C57BL/6J (male; 7-wk age; Cat # 0664) and LDLr-/- mice (male;
7-wk age; B6.129S7-Ldlrtm1Her; Cat # 2207) were purchased from the Jackson
Laboratory. Animals were housed in a controlled environment, with up to 5 mice per
cage, and provided water and food ad libitum. All mice were used after an acclimation
period of 1 wk during which they were placed on a normal mouse diet (ND). WT mice
were used primarily to generate baseline data for the planned experiments.
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To induce hypercholesterolemia, acclimated LDLr-/- mice were fed a diet enriched
in saturated fat (HFD) (21% wt/wt fat and 0.15% wt/wt cholesterol; Harlan Teklad; Cat #
TD88137) ad libitum for up to 8 wk. Age-matched LDLr-/- mice fed a ND served as
control animals. Animals underwent a weekly body weight check to ensure the uptake of
food.

4.1.2b Murine blood harvest
After the prescribed diet durations, mice were anesthetized with a lethal dose of
xylazine/ketamine mixture (90 and 10 mg/kg body weight; i.p.). When the mice lost
consciousness (i.e., no toe-reflex), the chest cavity was surgically opened to expose the
beating heart and blood (approximately 500 µl) was drawn from the left ventricle using a
23-gauge needle into a syringe containing EDTA (20 µl of 0.2 M). To ensure death, the
right atrium was also cut to exsanguinate the animals until their hearts stopped beating.
Blood was used for shear experiments within 3 h.

4.1.2c Analysis of murine neutrophil mechanosensitivity
Blood from WT or LDLr-/- mice that had been placed on either ND or HFD for 2,
4, and 8 wk was diluted 1:20 (v/v) in HBSS and subjected to 5 dyn/cm2 cone-plate shear
at RT for up to 10 min as described in section 3.1.2. The pseudopod activity of
neutrophils was assessed with microscopy as described in section 3.1.3b.
To verify the influence of cell membrane fluidity on the pseudopod retraction
responses of leukocytes, blood from LDLr-/- mice subjected to ND and HFD for 2 wk was
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pretreated with 0 – 0.05 mM BnOH and 10 nM fMLP for 1 min prior to shear
experiments (5 dyn/cm2; 10 min).

4.1.2d Plasma cholesterol quantification
The plasma levels of total, free, and esterified cholesterol were quantified for all
WT, ND, and HFD mice used in the present study. Briefly, plasma was harvested after
centrifugation of whole blood under 1000xg at 4 °C for 5 min. Plasma samples were
incubated (1:100 v/v) with Infinity Cholesterol Reagent (Sigma Aldrich) at 37 °C for 5
min; the absorbance was measured at 500 nm with a BioTek microplate reader and used
to calculated the concentration of total cholesterol in plasma samples based on the
standard curve generated following the manufacturer’s instruction. The concentration of
free cholesterol in plasma samples was quantified using the same Free Cholesterol E kit
with the same spectrophotometer as described in section 4.1.1c. The mass concentration
of esterified cholesterol was calculated as that of the sterol moiety plus fatty acid using
the established relationship [93],
.
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4.2 Results
4.2.1 The shear stress sensitivity of human neutrophils depends on the cholesterol-related
fluidity of the cell membrane
4.2.1a Cholesterol governs shear stress-mediated reductions in neutrophil pseudopod
activity by its influence on membrane fluidity
In line with neutrophil-like dHL60 cells (Figs. 3.4 and 3.5), populations of nonadherent human neutrophils pre-stimulated with 10 nM fMLP were deactivated by coneplate shear stress (5.0 dyn/cm2; 10 min) as reflected by significantly (p < 0.05) reduced
percentage of cells with pseudopod formation (static: 62±9% versus shear: 28±5%; p <
0.05).

Figure 4.1 Membrane cholesterol-enhancing agents dose-dependently decrease
membrane fluidity and impair shear-induced reductions in pseudopod activity.
Shear responses (%; 5 dyn/cm2; 10 min) were determined for human neutrophils
pretreated with 0 – 10 µg/ml cholesterol:MβCD (CH) and 10 nM fMLP. Membrane
fluidity for CH-treated cells was also measured and normalized to that of untreated cells.
Data are mean ± SEM from n ≥ 3 experiments. *, #p < 0.001 compared to samples
without CH treatment using Student’s t-test with Bonferroni’s correction.

Treatment of neutrophils with cholesterol:MβCD conjugates, to enhance their
membrane cholesterol content, had no detectable effects on their baseline pseudopod
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activity under static conditions (percentages of cells with pseudopods in all samples
fluctuated around 56% without significant changes). However, these treatments dosedependently attenuated shear-induced pseudopod retraction (Fig. 4.1). Specifically,
treating cells with increasing concentration of cholesterol complexes (between 0.5 - 10
µg/ml) resulted in gradual reductions in the ability of fluid shear stress to reduce the
number of neutrophils with pseudopods (indicative of an impaired pseudopod retraction
response). Notably, when treated with 10 µg/ml cholesterol conjugates, the
responsiveness of neutrophils to shear was reversed; in other words, shear exposure (5
dyn/cm2; 10 min) caused these cells to project pseudopods. The dose-dependent effect of
cholesterol complexes on the shear responses of neutrophils was verified by linear
regression analysis. A significant (p = 0.0062) negative correlation (r = -0.8253) was
detected between concentrations of cholesterol:MβCD conjugates used to treat
neutrophils and shear-induced reductions in the numbers of cells that projected
pseudopods (Table 4.1).
Interestingly, the attenuating effect of cholesterol:MβCD conjugates on shearinduced pseudopod retraction was related to their influence on membrane fluidity.
Incubation of neutrophils with cholesterol:MβCD decreased their membrane fluidity (Fig.
4.1). Specifically, the fluidity of neutrophil membranes negatively correlated (r = 0.8494; p = 0.0038) with the concentration of cholesterol conjugates used to treat
neutrophils (Table 4.1). When cholesterol conjugates were greater than 1 µg/ml, the
membrane fluidity of cholesterol-treated neutrophils was significantly (p < 0.001) lower
than that of untreated naïve cells.
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Table 4.1 Correlation analyses.

Finally, a correlation analysis was conducted between the membrane cholesteroldependent fluidity and the pseudopod retraction responses of cholesterol-treated
neutrophils to shear. The responsiveness of neutrophils pretreated with 0 – 10 µg/ml
cholesterol:MβCD to shear stress stimulation, in the form of reduced pseudopod activity,
positively correlated (r = 0.9783; p < 0.0001) with their membrane fluidity (Table 4.1).
These results therefore provide first evidence that neutrophil responsiveness to fluid shear
stress depends on their membrane cholesterol-related fluidity.

4.2.1b Intact neutrophil responsiveness to shear stress requires an optimal level of
membrane fluidity
To further verify the dependence of neutrophil mechanosensitivity to fluid flow
on membrane cholesterol-related fluidity, the combined effects of cholesterol:MβCD
conjugates and membrane fluidizer, BnOH, on the cell-deactivating effects of fluid shear
stress were tested. It was confirmed that the fluidizing effect of BnOH was independent
of any influence on membrane cholesterol levels (Fig. 4.2A). Specifically, treatment of
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leukocytes with 2 µg/ml cholesterol:MβCD conjugates either alone or followed by 2 mM
BnOH significantly (p < 0.05) increased cholesterol content in the cell membranes. In
contrast, incubation of cells with 2 mM BnOH alone had no effect on membrane
cholesterol levels.

Figure 4.2 Membrane fluidizers selectively counteract the attenuating effects of
membrane cholesterol enrichment on shear-induced reductions in pseudopod
activity (I).
A: Normalized membrane cholesterol was measured for untreated cells (UT) and cells
treated with 2 µg/ml cholesterol:MβCD (CH) and/or 2 mM BnOH. B: Shear responses
(%; 5 dyn/cm2; 10 min) were determined for neutrophils pretreated with different
chemicals. Data are mean ± SEM from n ≥ 3 experiments. Using one way ANOVA with
Bonferroni’s method, *p < 0.05 compared to samples without CH and BnOH treatment,
#p <0.05 compared to samples pretreated with CH alone.
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Although treatment of neutrophils with cholesterol:MβCD conjugates and/or
BnOH did not affect their pseudopod activity under static conditions (percentages of cells
with pseudopods in all samples fluctuated around 48% without significant changes), these
membrane modifications altered shear-induced deactivation (i.e., pseudopod retraction)
by these cells (Fig. 4.2B). Notably, the neutrophil shear response was significantly (p <
0.001) attenuated by either 2 µg/ml cholesterol:MβCD or 1 mM BnOH alone. Addition
of 2 mM BnOH to suspensions of cells pretreated with 2 µg/ml cholesterol conjugates
restored their shear responses to levels exhibited by untreated cells. BnOH at
concentrations either lower or higher than 2 mM (i.e., 1, 3, 5, and 7 mM), however, failed
to counteract the attenuating effects of 2 µg/ml cholesterol complexes on neutrophil
responses to shear.

Figure 4.3 Membrane fluidizers selectively counteract the attenuating effects of
membrane cholesterol enrichment on shear-induced reductions in pseudopod
activity (II).
Shear responses (%; 5 dyn/cm2; 10 min) were determined for neutrophils pretreated with
different chemicals. Data are mean ± SEM from n = 3 experiments. Using one way
ANOVA with Bonferroni’s method, *p < 0.05 compared to samples without CH and
BnOH treatment, #p <0.05 compared to samples pretreated with CH alone.

46

When shear-induced pseudopod retraction responses by neutrophils were
significantly (p < 0.005) blocked by 1 µg/ml cholesterol:MβCD, the concentration of
BnOH needed to reinstate their responses was shifted to 0.5 mM (Fig. 4.3). In this case,
BnOH at concentrations lower or greater than 0.5 mM (i.e., 0.2 and 1 mM) failed to
completely recover the neutrophil shear responses depressed by pretreatment with 1
µg/ml cholesterol:MβCD. Thus, there existed an “optimal” level of membrane fluidity
permissive for an intact pseudopod retraction response of neutrophils to shear stress
stimulation.

4.2.2 Hypercholesterolemia impairs shear-induced neutrophil deactivation
4.2.2a LDLr-/- mouse is associated with diet duration-dependent elevations in blood
cholesterol levels
LDLr-/- mice on ND exhibited significantly (p < 0.05) increased blood plasma
levels of free, esterified, and total cholesterol compared with WT mice on the same diet
(Table 4.2). However, whereas serum concentrations of esterified and total cholesterol in
these LDLr-/--ND animals increased in a time-dependent fashion, the levels of free
cholesterol remained constant throughout the 8-wk duration of the study (Table 4.2).
When placed on HFD, the levels of cholesterol (both free and esterified) in LDLr-/- mice
increased dramatically. Specifically, after 2 wk, the HFD group exhibited approximately
4-fold higher serum free and esterified cholesterol concentrations than those in the ND
group (Table 4.2). As HFD progressed for up to 8 wk, plasma concentrations of total,
esterified, and free cholesterol all rose in a diet duration-dependent fashion (Table 4.2).
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Table 4.2 Cholesterol levels in the blood plasma of LDLr mice.

4.2.2b Hypercholesterolemia impairs the shear stress regulation of pseudopod activity in
neutrophil populations
Consistent with the behavior of human neutrophils and dHL60 neutrophilic cells
(Figs. 3.4 and 3.5), neutrophil populations from WT mice exhibited reduced pseudopod
activity in response to fluid shear stress (5 dyn/cm2). Compared to cell populations
maintained under no-shear (t = 0) conditions, neutrophils in blood samples exposed to
shear stress for 10, but not for either 2 or 5, min exhibited significantly (p < 0.01) reduced
numbers of cells with pseudopod extension (Fig. 4.4). Similarly, neutrophils from LDLr-/mice under ND conditions for all diet durations tested (i.e., 2, 4, and 8 wk) were
deactivated by fluid shear stress with significantly (p < 0.05) reduced pseudopod
extension detected after 10 min of shear exposure (Fig. 4.5A). The degree of shearinduced reductions in pseudopod activity remained constant over 8 wk of ND feeding and
was comparable to that observed for neutrophils from WT mice.
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Figure 4.4 Shear induces time-dependent reductions in pseudopod activity of WT
neutrophils.
Neutrophils with pseudopods (%) were counted after 0 (control), 2, 5, and 10 min of
2
shear exposure (5 dyn/cm ). Data are mean ± SEM from n = 4 experiments. *p < 0.05
compared to control using one way ANOVA with Bonferroni’s method.

Under HFD conditions, both the baseline levels of pseudopod formation by
neutrophils under static conditions and their shear-induced pseudopod retraction
responses were altered. In contrast to mice subjected to ND for up to 8 wk (Fig. 4.5A),
animals on HFD exhibited diet duration-dependent changes in their baseline levels of
neutrophil activity (Fig. 4.5B). Compared to the blood from 2-wk HFD mice, the blood
from 4-wk HFD mice exhibited significantly (p < 0.05; by over 2-fold) elevated numbers
of activated neutrophils. Interestingly, the activated neutrophil counts in blood of 8-wk
HFD mice were similar to that observed for 2-wk HFD animals.
In terms of mechanosensitivity to fluid flow, although the percentage of activated
neutrophils from either 2-wk or 4-wk HFD mice was reduced by shear exposure, these
reductions were not statistically significant (Fig. 4.5B). After another 4 wk of HFD (i.e.,
8-wk HFD mice), neutrophil shear responses were completely reversed; shear exposure
significantly (p < 0.05) increased the number of neutrophils with pseudopods (Fig. 4.5B).
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Figure 4.5 Neutrophils from LDLr mice on HFD exhibit altered shear responses.
A and B: Neutrophils with pseudopods (%) were counted for samples maintained under
2
static or shear (5 dyn/cm ; 10 min). Data are mean ± SEM from n ≥ 4 experiments. *p <
0.05 compared to control (static) using Student’s t-test. #p < 0.05 using one way ANOVA
with Bonferroni’s method.

Linear regression analyses revealed significant (p < 0.01) correlations (total: R2 =
0.5; free: R2 = 0.5; esterified: R2 = 0.4) between serum concentrations of cholesterol and
neutrophil shear responses when combining data from both ND and HFD animals
(independent of diet condition). Specifically, as serum cholesterol concentrations
increased beyond some threshold level, shear-induced neutrophil deactivation decreased
and eventually reversed; i.e., cells projected pseudopods (Fig. 4.6).
Linear regression analyses were also conducted for each diet group separately. In
this case, whereas the neutrophil shear response for ND mice was independent of serum
concentrations of any forms of cholesterol (free, total, or esterified), the shear responses
of neutrophils from HFD animals exhibited significant (R2 = 0.5; p < 0.01) correlations
only with blood concentrations of free cholesterol (Fig. 4.6). These results provide
evidence that free cholesterol is a dominant factor in the blood that governs the neutrophil
mechanosensitivity to shear stress.
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Figure 4.6 Neutrophil shear response correlates with the plasma level of free
cholesterol.
A-C: Neutrophil shear response (%) was plotted versus the concentrations of free (A),
-/total (B) or esterified (C) cholesterol in the plasma of LDLr mice fed either a normal
(ND), or a high fat diet (HFD) for up to 8 wk.
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4.2.2c Benzyl alcohol influences shear-induced deactivation by neutrophils from LDLr-/mice

Figure 4.7 Membrane fluidizers influence the shear responses by neutrophils from
-/LDLr mice.
A and B: Neutrophils with pseudopods (%) were counted for samples maintained under
2
static or shear (5 dyn/cm ; 10 min). Data are mean ± SEM from n = 6 experiments. *p <
0.05 compared to control (static) using Student’s t-test.

Whole blood from 2-wk ND mice stimulated with 10 nM fMLP exhibited
significant (p < 0.05) reductions in pseudopod activity of neutrophils in response to shear
exposure (5 dyn/cm2; 10 min) (Fig. 4.7A). Exposure of similar blood samples to shear
stress in the presence of 0.01 – 0.05 mM BnOH led to diminished and eventually
reversed shear-induced pseudopod retraction response (Fig. 4.7A). Specifically, treatment
of stimulated blood with 0.01 mM BnOH attenuated reductions in pseudopod formation
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by neutrophils after shear exposure. Incubating similar blood samples with 0.02 mM
BnOH, however, significantly (p < 0.05) increased pseudopod activity of neutrophils
after shear exposure. When the same blood was sheared in the presence of 0.05 mM
BnOH, a similar increase in the number of activated neutrophils was observed relative to
unsheared samples, but this effect was not statistically significant.
Consistent with prior observation (Fig. 4.5B), exposure of fMLP-stimulated blood
harvested from 2-wk HFD animals to shear failed to elicit significant reductions in the
number of neutrophils with pseudopods. In contrast, the pseudopod activity of stimulated
neutrophils was significantly (p < 0.05) reduced by shear exposure in the presence of 0.01
mM BnOH (Fig. 4.7B). BnOH at concentrations higher than 0.01 mM (i.e., 0.02 and 0.05
mM) completely abolished this shear response with similar levels of neutrophil
pseudopod activity detected for both sheared and unsheared samples (Fig. 4.7B). These
results suggest that hypercholesterolemia-induced blockade of shear-induced pseudopod
retraction occurs, at least in part, via the effects of blood cholesterol elevations on
neutrophil membrane fluidity.
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CHAPTER 5 THE INFLUENCE OF MECHANOSENSITIVE CONTROL OF
NEUTROPHIL ACTIVITY ON MICROVESSEL FLOW RHEOLOGY
Fluid shear stress mechanotransduction serves to deactivate neutrophils under
physiological conditions and, therefore, may have significant effects on their rheological
(e.g., tumbling) behavior in the microvascular blood flow. To link shear stress
mechanotransduction (as reflected by pseudopod retraction, CD18 cleavage, or both) to
leukocyte flow behavior, the apparent viscosity of cell suspensions, an important
parameter describing flow rheology, was examined during shear exposure.
Additionally, a customized microfluidic network resistance chamber consisting of
an array of microchannels that mimic the small vessels of microcirculation was fabricated
and used to assess the effects of pseudopod formation by neutrophils on flow resistance
of cell suspensions in vitro. These studies were conducted to highlight the critical role of
shear-induced pseudopod retraction in promoting efficient microvascular flow.
Finally, the reactive hyperemia response in skeletal muscles (i.e., gastrocnemius)
was assessed during the development of hypercholesterolemia in LDLr-/- mice. Reactive
hyperemia is the transient increase in blood flow that occurs following brief ischemia. It
reflects the regulation of microvascular blood flow (i.e., changes in the peripheral
hemodynamic resistance). As such, results from these studies may provide in vivo insight
into the contributions of an impaired neutrophil shear response to hypercholesterolemiarelated microvascular flow dysregulation, a contributing factor for microvascular
dysfunctions.
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5.1 Methods
5.1.1 Kinetic analysis of the impact of shear stress mechanosensitivity on the leukocyte
flow behavior
Human leukocyte-enriched plasma was harvested as described in section 3.1.1b.
Leukocytes were incubated in HBSS (1:10 v/v) containing 10 nM fMLP for 10 min, and
subsequently subjected to fluid shear stress (shear rate: 450 s-1) for 10 min in the same
buffer using a computer-interfaced DV-II+PRO digital cone-plate viscometer
(Brookfield). This set up exposed cells to a constant shear stress field (~ 5 dyn/cm2). The
temperature of cell suspensions during viscometry was maintained at RT using a water
jacket cooling system incorporated into the lower plate. The viscosity of cell suspensions
during cone-plate flow exposure was recorded at 1-min intervals for the 10-min duration
of experiments using Wingather 32 software (Brookfield).
In some experiments, leukocytes were treated with either membrane-modifying
agents (cholesterol:MβCD conjugates or BnOH; see section 4.1.1a) or E64 (28 µM; see
section 3.1.4a) prior to or during 10 nM fMLP stimulation. These studies assessed the
involvement of membrane fluidity and CD18 cleavage-mediated platelet binding in
kinetic viscosity measurements.
In separate experiments, pseudopod activity and platelet binding during shear
exposure were examined for similar leukocyte suspensions with microscopy (see section
3.1.3b) and flow cytometer (see section 3.1.4b), respectively.
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5.1.2 Analysis of the impact of neutrophil activation on microchannel flow resistance
5.1.2a Design of microfluidics flow chamber
A microfluidic network resistance chamber was developed based on Stokes
approximation of creeping fluid flow where the Reynolds Numbers for planned flow rates
are extremely small (< 1) ensuring laminar flow conditions [94]. The micronetwork
chamber consisted of a single microchannel (w: 500 µm; h: 50 µm; square conduits) that
eventually splits into a network of 20 microchannels (w: 20 µm; h: 50 µm; l: 1 cm)
arranged in parallel. These parallel microchannels eventually reconnect into a single
downstream channel (w: 500 µm; h: 50 µm) that drains to the atmosphere. A negative
master of this design (Fig. 5.1A) was fabricated by Dr. Palaniappan Sethu (University of
Louisville, KY) according to published procedures [95].

Figure 5.1 Design of the microfluidic network chamber used in the present study.
A: A negative master of the desired microfluidic-based design for micronetwork
chambers was fabricated using standard soft lithography. B: A PDMS replica was bonded
to the glass slide. C: A region of the micronetwork chamber showing the parallel array of
20 x 50 µm microchannels.
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5.1.2b Micronetwork chamber fabrication
Polydimethylsiloxane (PDMS) replicas of the flow chamber were generated by
pouring a mixture of silicone elastomer and curing agent (10:1 v/v) onto the negative
master and baking it at 65 °C for 1 h. Holes for inlet and outlet ports on the PDMS
replicas were made using a blunt 20-gauge needle. After being cleaned with oxygen
plasma (1% oxygen, 60 s) in a plasma cleaner (Harrick Plasma), PDMS replicas were
bonded to glass slides to form the custom network flow chambers (Fig. 5.1B). This
chamber design allowed for its placement on an inverted microscope to directly visualize
the flow behavior of cells within the channels during flow experiments.

5.1.2c Cell preparations
Human neutrophil populations were purified from whole blood by two-step
Histopaque-Percoll gradient centrifugation as previously established [96] and
subsequently resuspended in PBS at 2x107 cells/ml. The resultant cell suspensions
contained >90% neutrophils.
Neutrophils (2x106 cells/ml) were stimulated with 10 nM fMLP for 10 min and
fixed with 0.2% glutaraldehyde (Electron Microscopy Sciences). Cells without
stimulation served as controls. In order to prevent pseudopod projections, neutrophils
were incubated with 30 µM cytochalasin B (CTB) [97], an inhibitor of F-actin
polymerization, for 30 min prior to fMLP stimulation. Fixed cells were diluted (1:10 v/v)
in 10% FBS in PBS prior to use.
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Neutrophil viability remained unchanged at 99% after CTB treatment as assessed
by the Live/Dead Double Staining Kit (see section 4.1.1b).

5.1.2d Network chamber flow experiments
A Statham pressure transducer and a syringe were connected to the inlet of the
micronetwork flow chamber via a 4-way stopcock and a piece of polyvinyl chloride
(PVC) tubing (inner diameter: 0.010″). Downstream of the microchannel network, a
piece of PVC tubing was connected to the outlet port to allow the perfusate to drain into
an open waste beaker. The syringe was mounted on a syringe pump (PHD2000; Harvard
Apparatus) to drive solutions into the flow chamber at controlled flow rates. The pressure
transducer was interfaced to a carrier demodulator (Validyne) and a data acquisition
device (NI USB-6008; National Instruments). The ability of the network flow chamber to
detect changes in flow resistance as a function of perfusate viscosity was validated using
0 – 30% glycerol solutions (Sigma Aldrich).
Prior to each cell experiment, the microchannels within the network chamber
were rinsed sequentially with 1 ml acetone, 2 ml diH2O, 1 ml ethanol, and 2 ml diH2O at
a flow rate of 10 ml/h. Subsequently, the microchannel surfaces (to be exposed to flowing
cell suspensions) within the network chamber were passivated with 10% FBS in PBS for
5 min to minimize non-specific cell binding.
For cell experiments, leukocyte suspensions were driven though the network
chamber at three sequential flow rates: 1 ml/h for 5 min → 2 ml/h for 10 min → 1 ml/h
for 10 min (Fig. 5.2). The infusing pressure at the inlet (relative to atmospheric pressure),
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corresponding to the pressure drop across the microchannel bed, was monitored as
voltage throughout the whole experiment by LabVIEW SignalExpress (National
Instruments). The pressure monitoring setup was calibrated using water manometry prior
to real-time data acquisition before experiments.

5.1.2e Data Analysis
Using Matlab (MathWorks), data (in voltage) was converted to pressure based on
the calibration curve generated for each experiment. The raw pressure data over the last 3
min of each flow rate phase (i.e., P1, P2, and P3 in Fig. 5.2) were averaged as a steady
pressure reading at each flow rate. To eliminate the variation associated with individual
chamber, the steady pressure at each flow rate was normalized to the value obtained at
the initial 1 ml/h phase (i.e., P1).

P2

P3

P1

Figure 5.2 A representative flow curve of neutrophil suspensions through the
micronetwork chamber.
Cells were perfused into the chamber at the following flow regimes: 1 ml/h for 5 min →
2 ml/h for 10 min → 1 ml/h for 10 min.
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5.1.3 Analysis of reactive hyperemia in hypercholesterolemia
5.1.3a Mice
Hypercholesterolemia was induced in LDLr-/- mice for up to 8 wk as described in
section 4.1.2a. Control animals were age-matched LDLr-/- mice fed a ND. At the end of
dieting, mice were subjected to experimental ischemic reactive hyperemia and real-time
tissue blood flow measurements for the gastrocnemius (thigh) muscle (see section 5.1.3b)
followed by phlebotomy (see section 4.1.2b).
For some experiments, neutropenia was induced in LDLr-/- mice that had been
placed on ND or HFD for 8 wk in order to confirm the role of neutrophils in the blood
flow recovery response to transient ischemia. Briefly, 1.0 mg of anti-Ly6G (1A8;
BioXCell), which depletes the mice of circulating neutrophils, was injected i.p. into
animals 36 h prior to use [98]. The induction of neutropenia was confirmed using flow
cytometry (section 3.1.4b); neutrophils in these animals accounted for < 1.0% of total
leukocytes as compared to around 10% in regular mice.

5.1.3b Blood flow recovery response to transient ischemia: ischemic reactive hyperemia
The blood flow recovery response of the gastrocnemius to 5-min hindlimb cuff
occlusion was examined for LDLr-/- mice using Near-Infrared (NIR) Diffuse Correlation
Spectroscopy (DCS). This technology was developed by Dr. Guoqiang Yu (University of
Kentucky, KY) and has been extensively validated to measure the relative change of
blood flow (rBF) in various tissues against a number of current technologies (e.g., laser
doppler, ultrasound doppler, fluorescence microsphere velocimetry, xenon-computed
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tomography, arterial spin labeled-magnetic resonance imaging) for monitoring blood
flow in deep tissues (up to centimeters below the skin) [99-101].
In the present study, mice were anesthetized by inhalation of 1% isoflurane
(Butler Schein). Hair overlying the gastrocnemius muscle on the left hindlimb was
shaved from the skin. A piece of PVC tubing (outer diameter: 0.05″) was loosely
wrapped into a noose (i.e., cuff) around the proximal end of the limb without restricting
blood flow. Distal to this, a DCS probe (i.e., a foam pad) housing a light source and a
detector separated by a distance of 6 mm was super-glued to this bared skin site. The 6
mm separation distance ensured detection of rBF in tissue regions 3 mm under the skin
surface deep within the muscle tissue [100, 101]. Fibers extending from the probe were
then attached to the DCS flow unit and rBF was measured for 5 min to acquire a baseline.
Cuff occlusion was then applied to the thigh by tightening the PVC tubing noose around
the proximal hindlimb until rBF was reduced to less than 10% of baseline levels and
maintained for 5 min, followed by cuff release (i.e., the PVC tubing was severed using a
high temperature surgical cautery pen) (Fig. 5.3A). Real-time rBF was recorded during
the whole process until it recovered to baseline (pre-occlusion) levels. Mice were
maintained at 37 °C for the duration of blood flow measurements using a heating pad.
At the end of experiments, mice were sacrificed and their blood was harvested
(section 4.1.2b) for analyses of neutrophil mechanosensitivity (section 4.1.2c) and
quantification of plasma cholesterol levels (section 4.1.2d).
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5.1.3c Data analysis of NIR-DCS-based measurements of reactive hyperemia
Using Matlab, the raw rBF data was plotted against time, and the highest value
after cuff release was identified as peak flow. In order to minimize the variations (e.g.,
due to noise), all data fluctuating within 10% of the peak flow value for each curve were
averaged and used as adjusted peak flow (APF) (Fig. 5.3B).

Figure 5.3 NIR-DCS-based relative blood flow (rBF) measurements during reactive
hyperemia.
A: Demonstration of experimental setup. B: A representative rBF curve consists of preocclusion, occlusion, and post-occlusion phases.

5.2 Results
5.2.1 Shear stress mechanosensitivity influences leukocyte rheological behavior
5.2.1a Suspension viscosity of leukocytes relates to their pseudopod activity but not to
their binding to platelets under shear exposure
At the initial time point (i.e., t = 30 s), suspensions of leukocytes in diluted
plasma mildly stimulated with 10 nM fMLP exhibited significantly (p < 0.05) higher
viscosity than cell-free plasma solution (1.19±0.05 cP for leukocyte suspensions versus
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0.95±0.00 cP for cell-free plasma). In contrast to the constant viscosity exhibited by cellfree plasma solution, suspension viscosity of fMLP-stimulated leukocytes decreased in a
time-dependent manner during 10-min exposure to a cone-plate shear flow (shear rate:
450 s-1; shear stress ranged from approximately 4 to 6 dyn/cm2) (Fig. 5.4). When shear
exposure time was ≥ 3 min, the viscosities of cell suspensions were significantly (p <
0.05) reduced compared to that for the same cell populations at 30 s.

Figure 5.4 Shear induces time-dependent reductions in the apparent viscosity of
leukocyte suspensions.
-1
fMLP-stimulated cells were subjected to viscometry at 450 s . Data are mean ± SEM
from n = 4 experiments. *p < 0.05 compared to t = 30 s using one way RM ANOVA with
Dunnett’s method.

For similar cell suspensions exposed to a time course of shear stress, the
percentage of neutrophils with pseudopods decreased in a time-dependent fashion.
Significant (p < 0.05) reductions in pseudopod activity occurred after only 1 min and
continued for the remaining shear exposure times (Fig. 5.5A).
In contrast, neutrophil-platelet adhesion in these suspensions increased during
shear exposure to a plateau (approximately, after 5 min of flow exposure). Leukocyte
suspensions exposed to shear stress for 5, 7.5, and 10 min exhibited significantly (p <
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0.05) elevated percentages of neutrophils with bound platelets relative to similar
suspensions maintained under static (t = 0) conditions (Fig. 5.5B). Further support for the
lack of influence of platelet binding on leukocyte suspension viscosity is the observation
that protease inhibitor E64, shown to enhance platelet binding under shear (Fig. 3.11B),
had no effect on the apparent viscosity of fMLP-stimulated leukocyte suspension
throughout the 10-min duration of shear exposure. Both naïve and E64-treated leukocytes
exhibited significantly (p < 0.05) reduced suspension viscosity after 2 min of flow onset
(Fig. 5.6).

Figure 5.5 Shear induces time-dependent reductions in pseudopod activity and
increases in neutrophil-platelet binding.
2
fMLP-stimulated cells were subjected to shear at 5 dyn/cm for 0 (control), 1, 2, 5, 7.5,
and 10 min. Data are mean ± SEM from n = 3 experiments. *p < 0.05 compared to t = 0
using one way ANOVA with Dunnett’s method.
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Figure 5.6 Protease inhibitor E64 had no effect on shear-induced reductions in
leukocyte suspension viscosity.
fMLP-stimulated cells with/without treatment of E64 were subjected to viscometry at 450
-1
s . Data are mean ± SEM from n = 3 experiments. *,*p < 0.05 compared to t = 30 s using
one way RM ANOVA with Dunnett’s method.

5.2.1b Leukocyte rheological flow behavior is modulated by the physicochemical
properties of the cell membrane
Leukocytes stimulated with fMLP in the absence (UT) or presence of 2 mM
BnOH exhibited similar levels of suspension viscosity at 30 s of flow onset (1.16 ± 0.06
cP for UT cells versus 1.05 ± 0.03 cP for BnOH-treated cells). In contrast to the
significant (p < 0.05 when t ≥ 4 min) reductions in suspension viscosity exhibited by
naïve leukocytes under shear, BnOH-treated cell suspensions did not exhibit significance
reductions in viscosity over the 10-min duration of cone-plate exposure (Fig. 5.7).
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Figure 5.7 Membrane fluidizer attenuates shear-induced reductions in leukocyte
suspension viscosity.
fMLP-stimulate cells with/without treatment of BnOH were subjected to viscometry at
-1
450 s . Data are mean ± SEM from n = 5 experiments. *p < 0.05 compared to t = 30 s
using one way RM ANOVA with Dunnett’s method.

Table 5.1 The apparent viscosity of leukocyte suspension at t = 30 s of flow onset.

Moreover, although treatment of leukocytes with 0 – 10 μg/ml cholesterol:MβCD
conjugates did not affect their suspension viscosity at t = 30 s of flow onset (Table 5.1),
these membrane cholesterol-enhancing agents dose-dependently impaired shear-induced
viscosity reductions (Fig. 5.8). Specifically, whereas suspensions of cells treated with 0,
2, and 5 μg/ml cholesterol complexes exhibited significantly (p < 0.05) reduced viscosity
after 4 min of shear exposure, 10 μg/ml cholesterol-treated leukocyte suspensions
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appeared to exhibit gradual increases in their viscosity after approximately 5 min of shear
that were not statistically significant as compared to their initial viscosity at t = 30 s.
Linear regression analyses revealed a significant correlation (R2 = 0.95; p < 0.05)
between the apparent viscosity of leukocyte suspensions after 10-min shear exposure and
the concentration of cholesterol conjugates used to pretreat these cells.

Figure 5.8 Membrane cholesterol-enhancing agents dose-dependently impair shearinduced reductions in leukocyte suspension viscosity.
0 – 10 µg/ml cholesterol:MβCD (CH)-pretreated cells were subjected to viscometry at
-1
450 s after fMLP stimulation. A: Time-course changes of viscosity. B: Correlation
between the endpoint viscosity measurement and CH concentrations. Data are mean ±
SEM from n ≥ 5 experiments. *p < 0.05 compared to t = 30 s using one way RM
ANOVA with Dunnett’s method.
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5.2.2 Neutrophil pseudopod formation is linked to microchannel flow resistance
5.2.2a Perfusate viscosity influences microchannel resistance to flow
Perfusion of 0 – 30% glycerol solutions through the microfluidic flow chamber
resulted in gradual increases in resistance (Fig. 5.9). Regression analyses pointed to a
linear correlation (R2 = 0.99; p = 0.0002) between flow resistance and viscosity within
the range of 0.8 to 2.0 cP (Fig. 5.9). This range covers those observed for leukocyte
suspensions during shear exposure (section 5.2.1). These results validated the use of flow
resistance measurements from the microfluidic network chamber to detect changes in the
apparent viscosity of the perfusate.

Figure 5.9 Microchannel resistance increases as the viscosity of perfusate rises.
0 – 30% glycerol solutions were perfused through micronetwork chamber at 0.5 ml/h for
5 min. Data are mean ± SEM from n =3 experiments.

5.2.2b Pseudopod formation alters flow resistance of neutrophil suspensions
After stimulation with 10 nM fMLP, the percentage of neutrophils with
pseudopod projection increased significantly (p < 0.05) as compared to that of naïve
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neutrophils without stimulation (Fig. 5.10). In contrast, CTB-treated neutrophils after
fMLP stimulation exhibited pseudopod activity levels similar to those of unstimulated
cells (Fig. 5.10).

Figure 5.10 The effect of neutrophil pseudopods on microchannel resistance.
Pseudopod formation (%) and pressure drop were assessed for untreated cells (UT),
fMLP-stimulated cells, and cells treated with CTB prior to fMLP (fCTB). Data are mean
± SEM from n = 3 experiments.

During preliminary experiments, fMLP-stimulated neutrophils perfused through
the microfluidic flow chamber at either 2 ml/h or 1 ml/h, on average, appeared to cause a
small increase in pressure drop across the microchannel array; these differences,
however, were not significant (Fig. 5.10). Interestingly, neutrophils that had been
stimulated with fMLP following treatment with CTB (an inhibitor of F-actin
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polymerization/pseudopod formation) and perfused through the microchannels induced
pressure-drops that were, on average, similar to those observed for untreated suspensions
(Fig. 5.10).

5.2.3 Neutrophil shear mechanotransduction is linked to microvascular flow regulation
during reactive hyperemia in hypercholesterolemia
The

present

study

explored

the

involvement

of

neutrophil

shear

mechanotransduction in the reactive hyperemia responses of hypercholesterolemic mice
to transient ischemia (i.e., 5-min blood flow occlusion). Consistent with our prior studies
using similar animals (Table 4.2), LDLr-/- mice fed a HFD exhibited time-dependent
increases in plasma cholesterol levels (Table 5.2).
-/-

Table 5.2 Cholesterol levels in the blood plasma of LDLr mice for blood flow
measurements.
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-/-

Figure 5.11 LDLr mice on HFD exhibit a gradual attenuation in reactive
hyperemia.
A: The rBF curves of 8-wk ND and HFD mice were overlaid. B: The adjusted peak flow
(APF) was calculated for animals on ND or HFD for up to 8 wk. Data are mean ± SEM
from n ≥ 6 experiments. *p < 0.05; 2-way ANOVA detected diet had effects, then
student’s t-test was performed between ND and HFD at each time point.

Measurements of rBF obtained from the gastrocnemius of mice fed either ND or
HFD for up to 8 wk using NIR-DCS were consistent with reactive hyperemia and similar
to that reported for humans [99, 100]. The rBF plot illustrated a stable baseline prior to
cuff occlusion, near-zero flow during cuff occlusion, and a period of flow overshoot
followed by recovery to baseline (pre-occlusion) flow levels after cuff release. Notably,
mice fed a HFD for 8 wk exhibited a more blunted rBF curve as compared to their ND
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counterparts (Fig. 5.11A). To quantify this difference, APF was calculated by averaging
rBF data fluctuating within 10% of the peak overshoot flow; all of the rBF data points
used to calculate APF occurred within approximately 1 – 2 min after cuff release (data
not shown).
Based on APF values, animals subjected to HFD for 2, 4, and 8 wk exhibited a
gradual impairment in their reactive hyperemia response to 5-min blood occlusion as
compared to time-matched ND animals (Fig. 5.11B). Whereas there were no differences
detected for the APF between ND and HFD group after 2 and 4 wk, the APF exhibited by
8-wk HFD animals was significantly (p < 0.05) lower than that observed for 8-wk ND
mice.

-/-

Figure 5.12 8-wk ND and HFD LDLr mice subjected to neutropenia exhibit similar
levels of adjusted peak flow.
A: The rBF curves of neutropenic ND and HFD mice were overlaid. B: The adjusted
peak flow (APF) was calculated for neutropenic ND or HFD mice. Data are mean ± SEM
from n = 6 experiments.

In order to assess the role of neutrophils in the reactive hyperemia responses of
mice to transient blood flow occlusion, approximately 90% of neutrophils were removed
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from 8-wk ND and HFD animals. Neutropenic HFD mice exhibited an rBF flow response
curve similar to that of their ND counterparts (Fig. 5.12A). In fact, there was no
difference in APF between ND and HFD mice subjected to neutropenia (Fig. 5.12B).
These flow results, taken together, suggest a role for neutrophils in the
hypercholesterolemia-induced impairment of reactive hyperemia response to transient
ischemia.

-/-

Figure 5.13 Neutrophils of HFD LDLr mice exhibit attenuated shear-induced
pseudopod retraction responses.
Shear responses (%) were assessed for animals on ND or HFD for up to 8 wk. Data are
mean ± SEM from n ≥ 6 experiments. *p < 0.05; 2-way ANOVA detected diet had
effects, then student’s t-test was performed between ND and HFD at each time point.

Consistent with results from prior studies (Fig. 4.5A), neutrophils in blood from
mice subjected to ND for 2, 4, and 8 wk exhibited similar reductions (around 50%) in
pseudopod activity in response to 5 dyn/cm2 shear stress for 10 min (Fig. 5.13). In
contrast, neutrophils from HFD animals exhibited a gradual attenuation of this response
(Fig. 5.13). Although neutrophil populations from 2-wk HFD mice appeared to exhibit a
reduced shear response, this difference was not significant. Neutrophils in the blood of
mice subjected to HFD for 4 and 8 wk exhibited significantly (p < 0.05) reduced shear
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responses. In fact, at these time points, shear stress increased the number of neutrophils
with pseudopods in the blood.
These data, combined, point to a role for the shear-sensitive control of neutrophil
activity

in

microvascular

flow

regulation

hypercholesterolemia.
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during

reactive

hyperemia

in

CHAPTER 6 DISCUSSION
In the absence of chemical agonists, leukocytes exhibit spontaneous pseudopod
activity as well as adhesion to other cells (i.e., leukocytes, platelets, ECs) under static
(no-flow) conditions in the in vitro and in vivo settings [43, 83]. These cells, however,
prevail in a quiescent state with few pseudopod projections, low surface expression of
cell-cell adhesion molecules, and minimal binding to other leukocytes or platelets when
flowing in the bloodstream of the physiological (non-inflamed, non-pathogenic)
circulation [43]. This discrepancy points to the existence of in vivo mechanisms that are
related to the fluid mechanics of blood flow and proactively prevent or minimize
leukocyte activation under physiological conditions.
Recently, fluid shear stress mechanotransduction has been established to be antiinflammatory in the physiologic circulation [5]. By inactivating leukocytes, particularly
the neutrophils, fluid shear stress stimulation ensures these cells remain in a rounded,
deformable, and non-adhesive state while flowing in the circulation. In doing so, shear
stress deactivation of the neutrophils serves to optimize their transit through the small
vessels of the microcirculation. Any factors that influence the sensitivity of leukocytes to
fluid shear stimulation could potentially affect their activation status and rheological
behavior to the point of compromising microvascular blood flow (e.g., enhanced flow
resistance, impaired tissue perfusion). In this regard, the present study provides the first
evidence that cholesterol enrichment impairs leukocyte shear mechanotransduction with
detrimental effects on leukocyte flow rheology and microvascular resistance. Moreover,
results of the present study point to the reduced mechanosensitivity of neutrophils to fluid
shear stress as a potential contributing factor for the hypercholesterolemia-related
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impairment of microvascular blood flow regulation during reactive hyperemia in
response to transient ischemia.

6.1 Membrane Cholesterol Regulates Shear-Induced Neutrophil Pseudopod
Retraction via Its Effects on Membrane Fluidity
Pseudopod retraction is the most obvious manifestation of the neutrophilinactivating effects of fluid shear stress. It occurs for both adherent and suspended cells
when subjected to a fluid shear field. In line with the observations of adherent neutrophils
retracting existing pseudopods in response to micropipette flow [102], cell populations
suspended in an uniform cone-plate shear field exhibited an acute response (within ~2
min of flow onset) with reduced pseudopod activity (Fig. 3.4). Moreover, once the shear
stress magnitudes reached a threshold level (approximately 5 dyn/cm2), the shear-induced
reductions in pseudopod activity by neutrophil populations occurred independently of
shear magnitudes up to 10 dyn/cm2 (Fig. 3.5). This range of shear stress is similar to that
typically found in the microcirculation [5].
Interestingly, pseudopod retraction by neutrophils in response to fluid shear
stimulation depends on the cholesterol content and/or organization in their cell
membranes. It has been shown that either increasing/reducing or sequestering cholesterol
in plasma membranes of migrating neutrophils impairs their pseudopod retraction
response to fluid flow stimulation [102]. In line with this, the present study demonstrated
that non-adherent neutrophil populations also exhibit a membrane cholesterol-dependent
pseudopod retraction response to shear stress stimulation (Fig. 4.1). Together, these data
point

to

membrane

cholesterol

as

an
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important

modulator

of

cellular

mechanotransduction and suggest the existence of an optimal membrane cholesterol level
permissive for an unimpaired fluid shear response for both non-adherent and adherent
neutrophils.
As an indispensable component of cell membranes, cholesterol in the unesterified
form (i.e., free cholesterol) modulates the properties of the lipid bilayer with profound
effects on the functions of membrane signaling molecules as well as the cells. In general,
these effects take place via two ways. For example, cholesterol can influence the
formation and functionality of membrane lipid rafts, the signaling platforms that
orchestrate outside-in and inside-out signal transduction [4]. Any changes in cholesterol
content or organization can disrupt raft structure, leading to the dissociation of raft
proteins [71]. The functional consequences of the lipid raft-related perturbations have
been demonstrated extensively in neutrophils for chemokine-induced calcium signaling,
extracellular regulated kinase activity, cell polarization, shape change, adhesion,
migration, integrin expression and actin polymerization [85-87, 103, 104].
Alternatively, membrane cholesterol participates in cellular signaling through its
impacts on membrane fluidity. Membrane fluidity (i.e., the inverse of microviscosity)
refers to the ensemble of physical properties that govern the motion (e.g., rotational and
lateral movements) of the phospholipid molecules in a membrane [77]. In this case, the
cholesterol-dependent fluidity physically influences the dynamics (such as the lateral
diffusion and structural changes) of membrane-associated proteins that drive downstream
cell functions [77, 78]. For instance, membrane fluidity has been shown to affect the
tertiary structure of GPCRs on ECs that undergoes conformational activation in response
to fluid shear stress [66]. Moreover, it has been demonstrated that membrane fluidity
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influences the chemotaxis of human neutrophils by regulating the conformationdependent binding affinity of FPRs and thus their sensitivity to fMLP stimulation [105,
106].
In the present study, the involvement of membrane fluidity in membrane
cholesterol-dependent shear mechanotransduction was initially highlighted by the parallel
decreases in both membrane fluidity and shear-induced pseudopod retraction response of
neutrophils treated with increasing concentrations of cholesterol conjugates (Fig. 4.1). In
fact, the linear regression analyses revealed a strong positive correlation (r = 0.9783; p <
0.0001) between neutrophil shear responses and membrane fluidity during cholesterol
enrichments (Table 4.1). This suggests that membrane cholesterol enrichment impairs
neutrophil shear mechanotransduction, at least, in part, by reducing the cell membrane
fluidity.
In order to further confirm the involvement of membrane fluidity in neutrophil
shear mechanotransduction, the use of a membrane fluidizer, BnOH, was adopted in the
present study. BnOH has been extensively used to fluidize the plasma membranes for a
variety of cell types, including erythrocytes, lymphocytes, endothelial and epithelial cells
[107-110]. Interestingly, BnOH, on its own, impaired shear-induced reductions in
pseudopod activity by neutrophils (Fig. 4.2B). Thus, either rigidifying or fluidizing the
cell membrane beyond its native state blocked neutrophil responsiveness to fluid shear
stress (Fig. 4.2B). This, therefore, points to an optimal membrane fluidity level for
neutrophil shear mechanotransduction that happens to fall within the physiologic range
for the cells.
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Furthermore, BnOH, in a concentration-selective manner, recovered the shearinduced pseudopod retraction response of neutrophils that had been blocked by
membrane cholesterol enrichment (Figs. 4.2 and 4.3). In fact, only one concentration of
BnOH completely recovered the shear responses of cholesterol-pretreated neutrophils.
Also, the BnOH concentration required to reinstate the shear responsiveness of
neutrophils that underwent membrane cholesterol enrichment depended on the
concentration of cholesterol-enhancing agents used to treat the cells.
Finally, it should be noted that the influence of cholesterol-related fluidity of cell
membranes on the neutrophil pseudopod retraction response to shear is independent of
cell adhesion, because similar observations were also made for adherent neutrophils
under micropipette flow [102]. Taken together, these data provide the first evidence that
lipid bilayer fluidity is critical for neutrophil mechanotransduction and further confirm
the existence of an optimal level of membrane fluidity permissive for an unimpaired
shear response.
Moreover, these in vitro results strongly point to the cell membrane as a
mechanotransducing compartment for neutrophils. This is reasonable considering its
strategic location between the intra- and extra- cellular milieu as well as its enriched
content of putative mechanosensors, e.g. FPR and CD18 integrins [48, 53]. There is,
however, a possibility that the cell membrane itself acts as a mechanotransducer. In this
respect, literature reports demonstrate increased membrane fluidity of either human or
bovine ECs within 5 s of exposure to 10 – 26 dyn/cm2 shear stress [66, 109, 111, 112].
However, the concept that the membrane, on its own, serves as a mechanotransducer
lacks the specificity that would explain the diverse range of responses to shear stress
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exhibited by different mammalian cell types. In line with the results of the present study,
it is more likely that membrane fluidity serves to modulate the sensitivity of cell-specific
mechanoreceptors to local shear stress distributions rather than to initiate cell
mechanotransduction.
One pathological implication of the present study relates to hypercholesterolemia,
a dominant risk factor for a variety of cardiovascular diseases including those associated
with sustained leukocyte activation and a dysfunctional microcirculation [2, 36, 113]. In
order to study the effects of hypercholesterolemia on the regulation of neutrophil activity
by fluid shear stress, LDLr-/- mice were used in the present study. These animals, when
placed on a diet supplemented with fat, developed gradually increasing plasma
cholesterol levels over a period of 8 wk compared to those on regular chow (Table 4.2),
as reported [114]. Presumably, this leads to the build up of a cholesterol concentration
gradient across the outer leaflet of the cell membrane that gradually drives cholesterol
into the neutrophil membranes predominantly via a receptor-independent pathway (e.g.,
endocytosis, direct surface exchange) that is incapable of saturation, as opposed to other
receptor-mediated internalization processes [4, 115, 116]. In fact, it has been reported that
neutrophils from humans or experimental animals exhibiting pathological elevations in
blood cholesterol levels display enhanced membrane cholesterol abundance as well as
reduced membrane fluidity levels [69, 117].
Consistent with the results from our in vitro membrane cholesterol enrichment
studies (Fig. 4.1) and compared to cells from LDLr-/- mice on a ND, neutrophils from
mice fed a HFD exhibited a reduced or even reversed shear response (Fig. 4.5). Notably,
the blockade of the neutrophil pseudopod retraction response to shear occurred as early as
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2 wk after placement on a HFD, which far precedes the appearance of pathological
symptoms related to hypercholesterolemia such as atherosclerotic lesions [2]. This
suggests that neutrophil shear mechanotransduction is highly sensitive to elevations in
plasma cholesterol. It is also in line with the reported increases in leukocyte adhesion and
emigration in the microcirculation of WT mice subjected to 2-wk of high cholesterol diet
[36]. Moreover, the observed aberrant shear mechanotransduction by neutrophils was
related to cholesterol-dependent membrane fluidity (Fig. 4.7).
It is important to point out that, in these animals, there may exist some other
contributing

factors

apart

from

cholesterol

for

the

impairment

of

shear

mechanotransduction by neutrophils. For example, elevated circulating pro-inflammatory
mediators (e.g., oxidized LDL [118]) associated with LDLr-/- mice on HFD may have
raised neutrophil activity to levels that suppress shear-induced deactivation [42].
Contrary to this was the independence of shear responses on the baseline pseudopod
formation by neutrophils from either ND or HFD animals (Fig. 4.5). It is also possible
that an altered regulation of O2- and NO related to hypercholesterolemia [119] impaired
neutrophil responses to shear since both of these molecules are involved in the leukocyte
shear mechanotransduction and exhibit membrane solubility [42, 46]. In addition, the
reduced neutrophil shear responses may be attributable to an enhanced cleavage of
membrane-bound receptors such as shear-sensitive FPRs [120]. However, the fact that
half of the variances associated with neutrophil shear responses were solely attributed to
changes in plasma concentration of free cholesterol (Fig. 4.6) with the remaining 50%
representing the contributions from all the other possible factors further substantiates the
important and dominant role of cholesterol.
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In summary, these results provide evidence that the cell membrane plays a central
role in neutrophil mechanotransduction of fluid shear stress. Specifically, membrane
cholesterol influences shear-induced pseudopod retraction responses by neutrophils, at
least in part, through its impact on membrane fluidity.

6.2 Shear Mechanotransduction Depresses Neutrophil-Platelet Adhesion by
Inducing Protease-Mediated Cleavage of CD18 Integrins
Another way by which shear mechanotransduction deactivates the neutrophils is
to down-regulate their surface expression of CD18 integrins. Under non-inflamed
conditions, fluid shear stress induces proteolytic cleavage of the CD18 ectodomain on
neutrophils, resulting in reduced levels of intact CD18 integrins [53, 54]. This process
involves rapid (within 1 min of flow onset) structural shifts in the CD18 tertiary structure
that likely expose cleavage sites for cysteine protease(s) released from intracellular
lysosomes under the actions of fluid shear stress [53].
The present study provides further insight into this mechanotransduction process
by demonstrating that fluid flow-induced down-regulation of CD18 depended on both the
shear exposure time (Fig. 3.6) and stress magnitude (Fig. 3.7). This response occurred
rapidly with CD18 surface expression reduced to a minimal level after 5 min of flow
onset (Fig. 3.6). Its acuteness is consistent with the other cell-deactivating effects (e.g.,
pseudopod retraction) of fluid flow (Fig. 3.4) [5]. Notably, a detectable CD18 cleavage
response required a threshold magnitude of shear stress within the range of 2.5 to 5
dyn/cm2 (Fig. 3.7) which is similar to that reported for the microcirculation and upstream
arteries/arterioles.
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Further evidence that shear-induced CD18 down-regulation involved a cleavage
process was the exclusive reductions in the extracellular, but not the cytosolic, domains
of these integrins on sheared neutrophils (Fig. 3.8) confirmed a cleavage process
occurring at the neutrophil surface. Under some conditions, cells reportedly downregulate their surface receptor expression via internalization. However, the absence of
any changes in neutrophil cytosolic CD18 staining in response to flow exposure, as
reported by Fukuda and Schmid-Schönbein using confocal microscopy, precludes the
possibility that shear stress lowered surface levels of CD18 integrins via receptor
internalization [54]. In fact, these investigators reported similar reductions in CD18
surface expression by either human or rat neutrophils using different antibodies that
target different epitopes on CD18 integrins (i.e., mAb MEM48 and Ab WT.3 against
human and rat CD18, respectively) [54]. Thus, the observed shear-induced cleavage of
CD18 was likely not due to flow-mediated changes in epitope accessibility.
Previous studies, using a panel of broad-spectrum and selective protease
inhibitors, have identified cysteine proteases, particularly cathepsin B as key enzymes for
the proteolysis of CD18 by neutrophils under shear [53, 54]. Notably, the degrees of
shear-induced CD18 cleavage observed in the present study were comparable to those
reported for either purified neutrophils or cells in undiluted whole blood exposed to 3 – 5
dyn/cm2 shear stress [53, 54]. This further confirmed that CD18 cleavage resulted from
shear-induced release of proteases from the cells and was not due to changes in the levels
of endogenous inhibitors of leukocyte proteases present in the blood plasma under
physiological (i.e., non-inflamed) conditions.
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One novel finding related to the present study was that monocytes and
lymphocytes, exposed to the same flow environments as neutrophils, also underwent
CD18 surface cleavage in a similar shear time and magnitude dependent fashion (Figs.
3.6 – 3.8). However, lymphocytes appeared to be more sensitive to fluid flow stimulation
requiring a lower shear magnitude to elicit significant (p < 0.05) reductions in CD18
surface expression, i.e., 2.5 dyn/cm2 required by lymphocytes as compared to 5 dyn/cm2
for neutrophils and monocytes (Fig. 3.7). Moreover, for monocytes, the reductions in
CD18 surface expression sometimes failed to reach significance (Fig. 3.8), suggesting a
less robust shear response by these cells. These results, therefore, point to these three
leukocyte subtypes exhibiting different sensitivities to shear stress.
Several factors may contribute to the cell type-specific shear sensitivity. For
example, neutrophils, monocytes, and lymphocytes exhibit quite different cell membrane
topologies in the form of membrane folds and/or microvilli. Thus, the heterogeneous
fluid stress distributions on the cell membrane imposed by the uniform macroscale shear
field of our cone-plate viscometer may have differed among the three leukocyte subtypes
with effects on the ability of flow to elicit either CD18 conformational activity or
protease release. Differences in cell topology may also impact the residence time of
proteases released by leukocytes in the vicinity of surface CD18 integrins. Since, at
resting (i.e., non-inflamed) states, LFA-1 and Mac-1 are predominantly localized in the
“valleys” between membrane folds/microvilli [121, 122], it would be expected that all of
these CD18 molecules on a given leukocyte surface would be equally susceptible to
cleavage independent of integrin subtype. In contrast, we observed an integrin subtypedependent cleavage response; in other words, shear exposure elicited cleavage of LFA-1
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(i.e., CD11a and CD18) on lymphocytes but proteolysis of Mac-1 (i.e., CD11b and
CD18) on neutrophils and monocytes (less robust) (Fig. 3.9).
A more plausible explanation for the differential responsiveness of leukocytes to
shear stress pertaining to CD18 cleavage may relate to the protease(s) required for
proteolysis. Along this line, it is possible that only lymphocytes, which typically do not
express detectable levels of Mac-1 [123], release protease(s) under shear to cleave LFA1. Although neutrophils and monocytes are also capable of releasing proteases involved
in LFA-1 shedding, this occurs only for activated cells during inflammation [124]. Our
experiments, however, were conducted in the absence of inflammatory agonist
stimulation.
Furthermore, although neutrophils and monocytes both exhibited Mac-1 cleavage
under shear exposure (Fig. 3.9), they may do so by releasing different proteases. In fact,
monocytes do not exhibit detectable extracellular enzymatic activity for cathepsin B, the
specific proteases involved in shear-induced CD18 cleavage for neutrophils [53], until
they differentiate into macrophages [125]. Therefore, monocytes under shear flow may
mobilize other proteases, such as serine proteases (e.g., elastase, proteinase-3, cathepsin
G) [126] and matrix metallo-proteinase-9 [127], all of which have been shown to be
capable of truncating Mac-1.
In the present study, the cysteine protease inhibitor E64 significantly (p < 0.05)
increased CD18 integrin levels on the surfaces of sheared neutrophils (Fig. 3.10)
consistent with previous reports [54], but this anti-protease had no significant effect on
CD18 surface cleavage for either monocytes or lymphocytes in the same suspension (Fig.
3.10). As such, the expression and enzyme kinetics of cell type-specific proteases may
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contribute to the different shear sensitivities exhibited by the three types of leukocytes.
Future work, however, is needed to confirm the involvement of proteases in shearinduced CD18 cleavage by the lymphocytes and monocytes.
It is also possible that the intrinsic structural properties of LFA-1 and Mac-1
influence their proteolysis following their conformational shifts under fluid flow. For
example, differences in the secondary and tertiary structures of LFA-1 and Mac-1 [123]
may impact cleavage sites and thus protease susceptibility rendering LFA-1 more prone
to protease-specific cleavage than Mac-1. Alternatively, shifts in LFA-1 conformation
may occur under lower shear stress magnitudes as compared to Mac-1. Interestingly,
although LFA-1 and Mac-1 prevail in an inactive (i.e., closed-bent) tertiary configuration
on resting leukocytes, the baseline level of LFA-1 in an open-extended (possibly
protease-susceptible) conformation is reportedly almost 9-fold higher than that of
spontaneously extended Mac-1 [51, 128]. Thus, the higher baseline of spontaneous
conformational activity for LFA-1 on lymphocytes may reduce the need for shearinduced structural shifts that facilitate cleavage of CD18 by proteases.
Finally, the leukocyte-specific expression pattern of integrins may explain the
dependence of shear-induced CD18 cleavage on cell type. Under static conditions, while
resting neutrophils express LFA-1 and Mac-1 at equivalent levels [129, 130], monocytes
express much more LFA-1 than Mac-1 at rest [123, 130]. As such, the substantial amount
of LFA-1 expressed on monocytes that was not cleaved by shear stress (Fig. 3.6)
accounted for a relatively higher proportion of the total CD18 integrins and thus may
have increased the variability associated with measurement of shear-induced cleavage of
CD18 (predominantly Mac-1) for these cells. Taken together, our results provide the first
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evidence that the leukocyte sensitivity to shear stress depends on the subtype of CD18
integrins involved and the proteases mobilized by these cells.
Since CD18 integrins, particularly LFA-1 and Mac-1, play a critical role in the
adhesive interactions between leukocytes and platelets [131-133], one physiological
implication of shear-induced CD18 cleavage relates to its potential regulation of
leukocyte-platelet binding under flow. Under non-inflamed conditions (i.e., in the
absence of biochemical stimuli), leukocytes suspended in flow fields in vitro
spontaneously interacted with platelets (Fig. 3.11). This observation agrees with previous
reports demonstrating that shear flow not only promotes cell-cell collisions but also upregulates P-selectin expression by platelets, both of which facilitate capture of leukocytes
by platelets [134, 135]. While initiating these loose and transient selectin-mediated
leukocyte-platelet interactions under non-inflammatory conditions, fluid flow may also
serve to either restrict or prevent firm adhesion by cleaving CD18 integrins. A key piece
of evidence supporting this possibility is the enhanced adhesion of neutrophils to platelets
as well as to fibrinogen (a Mac-1 ligand immobilized on platelets [136]) by E64-related
inhibition of shear-induced CD18 cleavage (Figs. 3.11 and 3.12).
Notably, the suppressing effect of shear-induced CD18 cleavage on neutrophilplatelet adhesion may have significant implications regarding microvascular blood flow
where the vessel diameters are 100 µm or less. In fact, binding to platelets physically
hinders neutrophil filtration through capillary-sized vessels [19, 20]. Moreover,
neutrophil-platelet aggregates have been reported to impose the greatest effects on
microvascular flow resistance in comparison to those by leukocyte deformability and
RBC aggregation [20]. Thus, the observed 10 – 20% changes in CD18 surface levels and
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platelet binding by neutrophils due to shear stress exposure may have a dramatic effect on
microvascular blood flow.
In fact, it is not surprising that we observed such small changes in CD18 surface
expression and platelet binding, as our studies were conducted with cells in the absence
of inflammatory agonist stimulation that were inactivated or, at the most, mildly activated
by our experimental manipulations. The fact that these changes were still associated with
significance in such a reduced inflammatory background further suggests the importance
of shear-induced CD18 cleavage as an anti-inflammatory mechanism in the physiological
blood environment.
In the case of monocytes and lymphocytes that were suspended with neutrophils,
the lack of an effect of cysteine protease inhibition (by E64) on platelet adhesion (Fig.
3.11) is consistent with the failure of E64 to influence CD18 surface expression under
flow conditions (Fig. 3.10). This provides further support that: 1) cysteine proteases (e.g.,
cathepsin B) may not be the only proteolytic enzymes that exhibit shear-sensitive release
and cleave CD18 integrins; 2) shear-induced CD18 cleavage by monocytes or
lymphocytes involves non-cysteine proteases; and 3) flow-mediated leukocyte-platelet
adhesion is closely related to shear-induced CD18 cleavage.
In summary, these results provide evidence that shear-induced proteolysis of
membrane-associated CD18 serves to restrict spontaneous cell-cell binding under
physiological conditions. This mechanotransduction process differs among the three
major leukocyte subtypes contingent on their expression of CD18 subtypes and/or
proteases.
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6.3 Shear Mechanotransduction Influences Neutrophil Flow Rheology
The rheological properties (i.e., behavior in a flow field) of neutrophils, e.g., their
cell size, potential irregularity of shape, stiffness, and adhesiveness, depend on their
activation status [8, 10]. While up-regulation of CD18 integrins upon cell activation
increases neutrophil adhesivity, projection of pseudopods by activated neutrophils
renders these cells larger, irregular, and stiffer [8]. Shear-induced cell deactivation in the
form of pseudopod retraction and/or CD18 cleavage, therefore, has important
implications concerning the flow rheology of neutrophils particularly in the
microcirculation where the vessel diameters are comparable to cell dimensions.
An important result of the present study was that transient reductions in the
apparent viscosity observed for suspensions of mildly stimulated leukocytes under shear
flow (shear rate: 450 s-1; shear stress: 4 – 6 dyn/cm2) (Fig. 5.4) tracked with the timedependent reductions in pseudopod formation (Fig. 5.5A). One possible explanation for
this relationship is that, when exposed to the linear flow velocity gradient created by
cone-plate viscometry, the mildly activated neutrophils with pseudopods likely tumbled
more and experienced more cell-cell collisions which disturbed the flow profile and
raised the apparent viscosity. This possibility is in agreement with Helmke et al. who
computationally showed the putative effects of leukocyte activation on the apparent
viscosity of blood [18, 61]. The underlying mechanism for these effects was that
activated leukocytes with increased tumbling in the flow field due to pseudopod
projection would undergo hydrodynamic interaction with RBCs and disturb their flow
profile [18, 61]. Considering that shear stress exposure elicits time-dependent reductions
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in pseudopod activity, the transient reductions in the viscosity of leukocyte suspensions
under shear likely reflect the neutrophil shear sensitivity.
In contrast, shear-induced transient reductions in leukocyte suspension viscosity
did not track with neutrophil-platelet binding under shear stress exposure (Fig. 5.5B) and
were not affected by blockade of shear-induced CD18 cleavage (Fig. 5.6). It is, therefore,
possible that, although binding of platelets to neutrophils could also modify the cell
geometry, these morphological changes are much smaller compared to those due to
pseudopod projection. It should be noted that the number of platelets bound per cell is
reportedly quite low for leukocytes mildly stimulated with 10 nM fMLP and it is less
likely for leukocyte-platelet interactions to lead to the formation of larger multi-cellular
aggregates [137]. Therefore, fluid shear stress appears to minimize the apparent viscosity
of leukocyte suspensions predominantly by inducing pseudopod retraction.
Notably, the effects of leukocyte shear mechanotransduction on the apparent
viscosity were influenced by modifications of membrane cholesterol/fluidity (Figs. 5.7
and 5.8) in a dose-dependent fashion similar to that observed for shear-induced
pseudopod retraction (Figs. 4.1 – 4.3). As such, shear stress-related effects on leukocyte
suspension viscosity also require the cells to exhibit an “optimal”, physiologic, level of
membrane cholesterol and fluidity. Moreover, the observed changes in the kinetic
viscosity measurements of neutrophils treated with membrane-modifying agents were not
due to the physical actions of cholesterol:MβCD conjugates on viscosities of the
suspending

buffer

(Table

5.1).

In

addition,

the

highest

concentration

of

cholesterol:MβCD conjugates tested (i.e., 10 µg/ml) was far below the pathological
levels (~ 240 mg/dl [1]) of cholesterol associated with cardiovascular diseases. Thus,
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shear-induced reductions in the apparent (dynamic) viscosity of leukocyte suspensions,
just like pseudopod retraction responses, are extremely sensitive to perturbations in the
cholesterol environment.
The results of the present study, therefore, closely relate the suspension viscosity
of leukocytes to their pseudopod activity. Through their impact on viscosity, the
projections of pseudopods by leukocytes may also manifest as an effect on microvascular
resistance. In support of this, a microfluidic network consisting of 20 microchannels with
dimensions comparable to vessel diameters of microcirculation was used to show, on
average, a slight increase in pressure drop across the microchannel network when
neutrophils in the perfusate were stimulated to express pseudopods (Fig. 5.10). It is
important to note that the recorded increases in pressure drop across the network due to
cell activation were not statistically significant. However, the fact that CTB inhibition of
F-actin polymerization (required for pseudopod projection) abrogated these small
increases in pressure drop provides some indication that an effect was detected. In fact, it
is not expected that viscosity changes due to cell activation would have a large impact on
microchannel flow resistance considering for example that, based on Poiseuille flow, tube
resistance is directly proportional to the viscosity of the perfusate. In comparison, cell
adhesion that effectively reduces the cross-sectional area of microvessels to flow would
have a more dramatic effect because of the dependence of flow resistance on the inverse
4th power of the vessel radius. In addition, viscosity measures of leukocyte responses to
shear (Figs. 5.4 – 5.8) were associated with a high degree of variation. Thus, it is likely
that the inability to detect significant differences in recorded pressure drops due to cell
activation may reflect the variations associated with cell suspensions and their influence
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on viscosity. In the end, further refinement of the microchannel dimensions or optimizing
the operating conditions (e.g., cell density) may lead to a more sensitive measure.
Despite a potentially small effect of leukocyte activation on the apparent viscosity
of perfusate and microchannel resistance, it may have significance in the in vivo
condition. Reportedly, elevations in microvascular resistance due to leukocytes can be
significantly amplified by the interactions of leukocytes with RBCs [18, 61]. Specifically,
the increased tumbling of activated leukocytes with pseudopods in the parabolic velocity
gradient of microvessels could disturb the RBC motion as a result of increased
intercellular tumbling collisions. This would then significantly elevate the apparent
viscosity of the suspending buffer with an enhancing effect on the microvascular flow
resistance. Along this line, pseudopod formation by leukocytes has been linked to
elevated blood pressure in hypertension that occurs due to increased peripheral
(micro)vascular resistance [138-140]. As such, shear mechanotransduction by neutrophils
may serve to maintain optimal blood flow rheology and minimize resistance in the
microcirculation by restricting pseudopod projection under physiological non-inflamed
conditions.
In order to verify the rheological effects of neutrophil shear mechanotransduction
in vivo, the reactive hyperemia response of gastrocnemius to acute ischemia (i.e., 5-min
blood occlusion) was examined for hypercholesterolemic LDLr-/- mice. Reactive
hyperemia is the transient increase in organ blood flow that occurs following temporary
vessel occlusion [141]. It is typically assessed by quantifying the peak flow overshoot
and the time required for blood flow to recover to pre-occlusion levels after reperfusion.
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In the present study, diet duration-dependent increases in cholesterol
concentrations (Table 5.2) in the blood of LDLr-/- mice tracked with a gradual attenuation
of reactive hyperemia in response to HFD for up to 8 wk (Fig. 5.11). This attenuation was
manifested as reduced peak flow (i.e., APF), which agrees with previous reports
demonstrating that hypercholesterolemia impairs the peak flow of reactive hyperemia in
microvessels [25, 142]. The impaired vasodilation of arterioles due to endothelial
dysfunction has been implicated in this hypercholesterolemia-related microvascular
dysfunction [25]. However, it is also possible that neutrophils within microvessels that
are activated upon blood occlusion [43, 143] play a role in the impaired reactive
hyperemia response by their effects on viscosity and flow resistance. In fact, neutrophils
accumulate at sites of ischemia after reperfusion [144, 145], which is exacerbated in the
face of hypercholesterolemia [113] and to the detriment of microvascular blood flow and
tissue perfusion [12, 146]. A key piece of evidence supporting a neutrophilic involvement
is our finding that depletion of neutrophils restored the peak flow in HFD mice to the
level exhibited by their ND counterparts (Fig. 5.12). Thus, the presence of activated
neutrophils influences the reactive hyperemia response, at least, in the early phase (i.e., ~
1 – 2 min after cuff release).
Notably, the procedure used in the present study to induce reactive hyperemia, i.e.
reperfusion response to transient ischemia, likely created a scenario in which neutrophils
sediment, extend pseudopods, and migrate on the vascular endothelium during blood
stasis and then retract pseudopods and detach into the flow field upon restoration of blood
flow. Such a scenario has been mimicked using intravital microscopy examination of
microvascular networks of rodents (e.g., mesentery, cremaster muscle) [42, 43, 45]. In
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these experiments, activated neutrophils retracted their pseudopods immediately after
release of upstream blood flow occlusion imposed by a blunt micropipette tip with
dramatic changes in cell length/morphology observed within 1 – 2 min [43].
Interestingly, this time frame is well within the range where the peak flow appeared and
where the reactive hyperemia response was affected by the presence of neutrophils (Figs.
5.11 and 5.12). Based on this, shear stress mechanotransduction may be linked to the
peak blood flow of reactive hyperemia by its regulation on neutrophil rheology.
This connection was further supported by the observation that the time-course of
reductions in peak flow tracked with the impairment of shear-induced pseudopod
retraction responses by neutrophils in the blood of hypercholesterolemic mice (Figs. 5.11
and 5.13). Moreover, the fact that the defect in neutrophil shear-mechanotransduction
was detectable at least 4 – 6 wk earlier than the time required for impairment of reactive
hyperemia to develop during hypercholesterolemia (Figs. 5.11 and 5.13) [25] points to
the

shear

mechanosensitivity

of

neutrophils

as

a

potential

predictor

for

hypercholesterolemia-related microvascular dysfunction.
In fact, the shear stress and viscometry experiments conducted for the present
study may recreate the reactive hyperemia scenario for the neutrophils in the in vitro
setting since neutrophils were exposed to shear immediately after activation under noflow conditions. A potential difference is that our in vitro, flow-based analyses involved
mildly stimulated neutrophils in suspension while reactive hyperemia may reflect the
responses of migrating neutrophils. Both adherent and suspended neutrophils, however,
respond to shear by reduced pseudopod activity within 10 min of the onset of flow
exposure. Also, the effects of neutrophil shear responses on viscosity (Figs. 5.4 – 5.8)
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occurred within the same time frame as reactive hyperemia. Thus, reactive hyperemia
may probe the mechanosensitive impact of neutrophils on microvascular flow.
In summary, the results of the present study provide evidence that fluid shear
stress mechanotransduction by neutrophils, particularly in the form of pseudopod
retraction, modulates their rheological flow behavior. Furthermore, a reduced
mechanosensitivity, e.g., due to membrane cholesterol enrichment, may be a contributing
factor for the hypercholesterolemia-related impairment of microvascular blood flow
regulation during reactive hyperemia.
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CHAPTER 7 CONCLUSIONS
The present study provides further evidence that the mechanotransduction of fluid
shear stress is an anti-inflammatory mechanism for leukocytes, particularly the
neutrophils, in the physiological non-inflamed circulation. Specifically, fluid shear stress
deactivates neutrophils not only by preventing their pseudopod formation, but also by
inducing protease-mediated CD18 proteolysis to the point of minimal interactions with
other cells. As such, this mechanobiological mechanism appears to optimize
microvascular blood flow by regulating the rheological behavior of neutrophils. The
results of the present study also provide the first evidence that membrane cholesterol
plays a critical role in neutrophil shear mechanotransduction particularly as it relates to
cellular mechanosensitivity. Along this line, membrane cholesterol-related perturbations,
e.g., due to hypercholesterolemia, may affect leukocyte flow rheology through their
effects

on

the cell sensitivity to

fluid shear stress. The defective shear

mechanotransduction by neutrophils, therefore, may expedite the initiation of
microvascular dysfunction associated with hypercholesterolemia, contributing to
obstruction of microvessels as well as reduced tissue perfusion.
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